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Gene fragments encoding both toxins A and B in a very 
toxigenic strain of Ç. difficile was cloned into bacterio¬ 
phage A,gtll by using duplex oligonucleotide adaptors. 
Twenty-two recombinant phages were detected by screening the 
library with toxin A antiserum. Twenty-one recombinants 
spontaneously lost their insert fragments, leaving only one 
consistently verifiable clone, Xcdl9. The DNA insert in 
A,cdl9 was estimated to be 0.3 kbp and hybridized to a 0.35 
kb, 4.35 kb, and 16kb fragments from Taql, Pstl, and Hindlll 
RE cleavage respectively. Nucleotide sequence of A.cdl9 
revealed an open reading frame which encodes a peptide with 
putative isoelectric point of 5.9. Twelve recombinant 
phages were detected by screening the library with antiserum 
against toxin B. Three insert sizes of 1.5, 1.9, and 2.5 kb 
were cloned for toxin B. Four peptides with Mr of 145,000, 
132,000, 56,000 and 38,000 were identified on a Western blot 
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analysis of the expression products from the recombinants. 
Expression of the peptides were independent of induction of 
the lac operon by IPTG. Peptides encoded by both toxin gene 
recombinants phages were not cytotoxic for CHO cells and 
affinity purified antibodies from the recombinants did not 
inactivate the activity of the toxins. 
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It is routine to establish the identity of many infec¬ 
tious diseases by demonstrating the presence of an organism 
or its toxins in a patient. For various clostridial species 
which produce a wide range of toxins with activities on the 
gastrointestinal tract, this mode of identification holds 
true, but for others the process can become quite obscure 
and inapt. Unlike some members of the genus that are fairly 
easy to diagnosed, the association of Clostridium difficile 
with diarrhea and colitis, two frequent gastrointestinal 
disorders, is not very direct. In fact most cases of coli¬ 
tis are unconnected to Ç. difficile, however, the associa¬ 
tion with pseudomembranous colitis (PMC) is well established 
and found to be almost exclusively caused by the organism. 
PMC is a disease characterized by formation of patchy to 
confluent pseudomembrane on the intestinal and rectal mucosa 
with accompanying self-limiting to sometimes life- 
threatening diarrhea. The pathogenesis of pseudomembranous 
colitis very much remains as elusive today as it was since 
its discovery in mid 1970's. A common complication of anti¬ 
biotic therapy, PMC was first contemplated to be caused by 
Clostridium sordellii because the cytopathogenic effect in 
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cultured cells as induced by patient fecal extract could be 
neutralized with Ç. sordellii antitoxin [54, 84, 122]. 
However, the organism was discounted as the causative agent 
after repeated unsuccessful attempts to isolate the bacte¬ 
rium from faeces of patients. Thereafter, attention was 
focused on C. difficile because it was isolated from more 
than 90% of fecal samples previously examined for presence 
of C. sordellii [5]. C. difficile was later confirmed as 
the étiologie agent after antibiotic-treated experimental 
animals developed cecitis after being challenged with either 
the organism or its cell-free culture supernatant [6,21]. 
C. difficile produces two large and lethal toxins 
designated toxin A and toxin B based on their elution 
profile from ion exchange columns [117]. Toxin A is an 
enterotoxin which causes hemorrhagic tissue destruction and 
enteric fluid accumulation without affecting adenylate 
cyclase activity. These response are not characteristic of 
typical enterotoxins, such as cholera toxin, which affect 
cyclic adenosine 3',5' monophosphate (cAMP) levels and cause 
little mechanical damage to tissues [115]. Toxin B is a 
potent cytotoxin devoid of enterotoxic activity but requires 
internalization for expression of cytopathogenic effects. 
It is a lethal toxin when injected intravenously or ad¬ 
ministered intragastrically with sub-lethal amounts of toxin 
A [61]. However, toxin A is not needed if mechanical 
physical damage is inflicted on the cell. Toxin B causes a 
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disorganization of the microfilament system including 
condensation of actin filament around the nuclei 
consequently decreasing DNA, RNA and protein synthesis 
[105] . It also increases the level of cyclic guanosine 
3',5' monophosphate (cGMP) and induces irreversible loss of 
fibronectin from cell surfaces [1,110] 
Both toxins are essential for pathogenesis of the 
disease as toxoid A and B were required to protect hamsters 
from clindamycin-induced Ç. difficile-associated ileocecitis 
[49,55]. A significant number of individuals, infants more 
so than adults, harbor toxigenic Ç. difficile and cytotoxin 
in their intestinal tracts. In certain cases the concentra¬ 
tions of toxins found in these asymptomatic individuals 
parallel concentrations in intestinal tracts of adults with 
pseudomembranous colitis [38,96]. There are still no 
concise explanations regarding these observations in part 
because the mode of Ç. difficile intestinal colonization, 
toxin composition, mechanisms of toxin expression and 
disease process remains to be elucidated. 
Study of toxin genes of Ç. difficile at the molecular 
level was initiated in this investigation. Fragments of 
both toxin genes were cloned and partially characterized in 
lambda based cloning vectors. A highly antigenic and stable 
segment of toxin A was subsequently sequenced. This study 
is part of a significantly broad project focusing on the 
identification of antigenic, toxic and binding sites present 
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on Ç. difficile toxins. Characterization of these important 
regions will allow future studies on the pathogenicity and 
immune response induced by this disease. 
CHAPTER II 
REVIEW OF LITERATURE 
Clinical Significance of Antibiotic-Associated Pseudo¬ 
membranous Colitis 
Clostridium difficile. is a toxin producing strict 
anaerobic bacterium implicated as a causative agent of 
antibiotic-associated diarrhea and pseudomembranous colitis 
(PMC), an acute ailment affecting both colonic and rectal 
mucosa [29,36,37,54,68]. A disease ranging in clinical 
severity from mild self-limiting diarrhea to severe and 
sometimes life-threatening colitis, PMC and other forms of 
colitis are well established complication of antibiotic 
therapy [6,7,11, 12,13,16,22,105,109]. 
PMC is a syndrome of the lower gastrointestinal tract 
reported to occur through disruption of normal microecology 
of intestinal tract from antibiotic therapy, creating favo¬ 
rable conditions for overpopulation and production of patho¬ 
logic amounts of toxin by the organism [43,88,104]. PMC is 
endoscopically characterized by progressive disruption of 
intestinal microvilli, production of mucosal inflammation 
and formation of exudative plaques on the colonic mucosa 
[7] . There has been no documentation regarding actual 
observation of bacterial invasion of the pseudomembranes. 
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Plaques formed appear as discrete elevated structures of 
which the largest are approximately 2 cm in diameter and 
composed of calcified fibrinous necrotic epithelial cells. 
As disease state progresses, the plaques often enlarge and 
unite to form loosely adherent pseudomembranes. 
Besides diarrhea, a conspicuous symptom, most patients 
with antibiotic associated colitis experience a cramping 
hypogastric pain, abdominal tenderness, leukocytosis and 
fever [18] . Onset of diarrhea is reported to be sporadic 
among patients usually occuring 4 to 9 days following start 
of antibiotic therapy or 5 days to 10 weeks after 
termination of treatment. Considerable evidence has 
accumulated to suggest that antimicrobial therapy involving 
a broad spectrum of antibiotics, including those to which Ç. 
difficile are sensitive, are capable of inducing PMC 
[6,9,13,36,68,93]. The only known exceptions at present are 
vancomycin and aminoglycosides. 
Colonization of intestine by resistant Ç. difficile was 
initially believed to be a response to decreased antibiotic 
tension following antibiotic therapy as well as obliteration 
of other non-resistant bacterial species that compete for 
nutrient in the environment. However, the causation and 
complexities of PMC were redressed when Rolfe and Finegold 
[87] reported that simultaneous administration of ampicillin 
and a non-absorbable (3-lactamase inhibitor protected hams¬ 
ters from ampicillin-induced ileocaecitis but led to fatal 
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syndrome upon termination of treatment. Their findings were 
very significant because it indicated retardation of Ç. 
difficile growth in healthy animals is due to a component or 
components produced in normal microenvironment of the 
intestine and not just presence of competitive bacteria. 
Resistant Ç. difficile strains are therefore, only able to 
colonize the bowel following ecological disturbance of the 
normal constituents by antimicrobial treatment. Another 
intriguing facet of this syndrome was evidence that gastro¬ 
intestinal tract colonization by the organism in patients on 
antibiotic therapy does not always result in C. difficile 
induced colitis [7,11,18,113]. The theory that additional 
complicated mechanisms are needed for manifestation of 
illness is very readily accepted at present. This view was 
supported by documented studies for which intestinal coloni¬ 
zation and toxin production were successfully induced by 
sub-inhibitory concentrations of antibiotics and in particu¬ 
lar, a finding that Ç. difficile isolates from penicillin- 
induced ileocecitis were susceptible to minimum inhibitory 
concentrations (MIC) of penincillin in vitro [31,44]. Also, 
frequent recovery of highly toxic strains from feces of 
healthy neonates and asymptomatic adults, as well as 
observations that disease state neither correlates directly 
with numbers of organisms or fecal toxin titer, indicate a 
need for additional explanation [18,57,113]. 
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In conjunction to therapy, route of antibiotic adminis¬ 
tration has been extensively evaluated and found to play an 
important role in antibiotic-associated colitis. For insta¬ 
nce, oral administration of clindamycin resulted in two to 
four times more frequent cases of PMC than intravenous and 
intramuscular routes of administration [103]. The same pro¬ 
file of higher incidence was observed for patients treated 
orally with other antibiotics (Table 1). 
Clinicians investigating the pathogenic role of Ç. 
difficile in the etiology of antibiotic-associated colitis 
have noted that PMC seldom develops in individuals who 
harbor toxin producing strains of the organism in their 
intestinal tracts. This is especially apparent in asympto¬ 
matic infants and young children under 1 year of age whose 
gastrointestinal prevalence of Ç. difficile was demonstrated 
to be as much as 90% [22,43,96]. Fecal isolation rate for 
healthy adults was established to be considerably less at 
only 2% to 4%, nevertheless, adults are more predisposed to 
Ç. difficile-associated colitis than young children [75] . 
The process which permits tolerance of Ç. difficile by 
infants is still elusive but researchers are focusing on 
antibodies acquired from maternal blood and breast milk. 
Presence of neutralizing antibodies to toxin A and B have 
been demonstrated in both maternal milk and serum of 
immunized lactating hamsters [49]. 
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TABLE 1. CLINDAMYCIN-ASSOCIATED COLITIS: INCIDENCE FROM 
ROUTE OF ADMINISTRATION. 
ROUTE TOTAL NUMBER OF NUMBER OF PATIENTS 
PATIENTS WITH PSEUDOMEMBRANOUS 
COLITIS 
Oral 80 13 
Intravenous 72 2 
Intramuscular 3 1 
Extrapolated from F.J. Tedesco, [103]. 
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Ç. difficile, previously named Bacillus difficilis. was 
first described in 1935 by Hall and O'Toole [40] following 
its isolation from fecal flora of healthy infants. It has 
been isolated from a variety of sources, but was not 
recognized as a human pathogen until 40 years later when its 
involvement in antibiotic-associated diarrhea was reported. 
During the last few years, Ç. difficile has acquired 
tremendous significance as a clinically important intestinal 
pathogen and has become the focal point of extensive 
research. Mechanisms by which Ç. difficile causes diarrhea 
and mucosal injury is not well understood, however, the 
pathogenicity of this organism is believed to be dependent, 
in part, upon its potential for producing toxins [6,54]. 
Most strains are toxigenic, producing at least two large 
toxins, toxin A (enterotoxin) and toxin B (cytotoxin), which 
are biologically, biochemically, and antigenically distinct 
[58,98,102,120]. In toxigenic strains, both toxins are 
expressed in equal amounts, however, levels of expression 
differ from strain to strain and are completely absent from 
non-toxigenic strains [62,63,120]. There are no published 
reports of strains expressing only one toxin. Ketley et al. 
[47] in a study to determine the production and release of 
toxins A and B by Ç. difficile, reported that large 
quantities of intracellular toxin B was observed during 
early log phase with extracellular accumulation during late 
log to early stationary phase, approximately 12 h. For 
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toxin A, small quantities, mostly cell associated, were 
detected during stationary phase (24 h) with a peak period 
at 72 h. Extracellular toxin A was detected in the medium 
24 h into the decline phase or approximately 48 h from the 
onset of logarithmic growth. Maximum extracellular accre¬ 
tion for both toxins was reported at 72 h to 96 h, but may 
be due principally to cell death and subsequent cell lysis. 
Physicochemical Characteristics of Toxins A and B 
Toxins A and B have been purified and characterized in 
various laboratories (Table 2), but controversies over the 
biochemical identity of both toxins still exist [74,80,99]. 
Toxin A has been isolated in relatively pure form while 
toxin B has been isolated to varying degrees of purity by 
several groups [4,80,86,99,101]. An isoelectric point (pi) 
of 5.5, as determined by isoelectric focusing, was establi¬ 
shed for the enterotoxin whereas a pi ranging from 5.0 to 
6.2 were reported for the cytotoxin [63]. However, since 
the cytotoxin readily precipitates at a pH of 3.8, it was 
suggested by Lyerly et al. [63] that the pi is much lower 
than previously reported values 5.0 to 6.5. This isoelec¬ 
tric property is currently widely employed in the purifi¬ 
cation of toxin A. Although no consensus has been reached 
regarding the native molecular weights of the toxins, there 
seems to be no objection that toxin A is the larger of the 
two toxins. Molecular weights of these hydrophobic 
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TABLE 2. SUMMARY OF THE PHYSICOCHEMICAL CHARACTERISTICS OF 
C. difficile TOXINS A and B. 




















AMINO ACID CONTENT 
Major asp, giy/ glu asp, giy/ glu 
his, met, cys his, met, cys Minor 
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amino acid-rich molecules, as analyzed on non-denaturing 
polyacrylamide gel electrophoresis (PAGE), have been 
estimated to range from 440,000 to 600,000 for toxin A and 
107.000 to 550,000 for toxin B [3,45,86,99,101,116]. 
Information on subunit composition of the toxins is 
emerging very slowly [4,67,80,99]. For instance, Lyerly et 
al. [63] reported that immunoaffinity purification of C. 
difficile cytotoxin using gel-coupled antibodies resulted in 
identification of five cytotoxic bands with molecular masses 
of 70,000 daltons, 160,000 daltons, 250,000 daltons, 280,000 
daltons and 340 daltons. The isolated cytotoxic proteins 
were shown to be immunologically related through cross 
immunoelectrophoresis using toxin B specific antibodies, an 
observation which suggest that multiple forms of the toxin 
may exist. It is also possible to associate the spectrum of 
bands present as products of autolysis, limited enzymatic 
degradation, or subunit aggregate compositions of the 
cytotoxin. The aggregation theory was advanced by Pothoula- 
kis et al. [80] on the basis of evidence that a single 
50.000 dalton monomer was formed upon exposure of toxin B to 
SDS and various reducing agents. Based on the native mole¬ 
cular weight of their toxin preparation, they concluded that 
toxin B exists as aggregates of 8 to 10 monomers in aqueous 
buffers. Banno et al.[4] obtained a single protein band 
with a mobility of approximately 190,000 daltons to 200,000 
daltons on SDS-PAGE gels after SDS and {3-mercaptoethanol 
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treatment of the toxin. In another recent publication [67], 
the molecular weight of toxin B was estimated to be 250,000 
daltons by denaturing SDS-PAGE, and no subunits were 
apparent when the toxin was reduced and analyzed on gels. A 
50,000 dalton protein lacking cytotoxic activity was shown 
to be associated with toxin B in the same publication. This 
50,000 dalton protein was confirmed to exhibit the proper¬ 
ties of the protein isolated by Pothoulakis and was 
confirmed to be a contaminant which, under nondenaturing 
conditions, has physical properties similar to those of 
toxin B [67,115]. These reports are still controversial 
since they have not been successfully replicated by other 
investigators. 
Despite these differences between the two major toxins 
of Ç. difficile, both have been shown to share many similar 
biochemical characteristics. Both toxins retain their 
activity after incubation at 37°C for 16 h, but are heat 
labile at 56°C or greater. Toxin B, however, is more prone 
to inactivation in acidic and alkaline solutions than toxin 
A. Both toxins are inactive at pH 2.0 and are susceptible 
to proteolytic enzymes, including pronase, trypsin and 
chymotrypsin [4,58,99]. The purified toxins are similar in 
amino acid composition, with high amounts of glycine, 
glutamic acid and aspartate, and low amounts of methionine, 
histidine and cysteine [26,118]. A reduction in associated 
cytotoxicity upon treatment with N-acetyl maleimide 
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treatment was reported by Chang et al. [20], suggesting that 
sites relevant for the toxic action of the proteins may 
contain sulfuhydryl groups and disulfide bonds. Both toxins 
are negatively charged at neutral pH, extremely sensitive to 
oxidation and appear to be relatively hydrophobic proteins 
by virtue of retention on hydrophobic gels [42]. 
Biologic and Immunologic Properties of Toxins A and B 
Examination of the biological activities of the two 
toxins by Taylor et al. [102], Sullivan et al. [99] and 
Lyerly et al. [58] revealed that toxins A and B possess 
various distinct biological activities (Table 3) . Although 
toxin A and toxin B are cytotoxic to a variety of different 
cell lines, toxin B has been shown to be greater than 1,000 
times more cytopathic (lethal) for tissue culture cells than 
toxin A [7,20,26,29,80], and contains approximately 83% of 
the cytotoxic activity [4]. Toxin A elicits vascular per¬ 
meability, leading to a viscous hemorrhagic fluid response 
in ligated rabbit ileal loops, whereas toxin B produced a 
weak variable response, with no apparent haemorrhage 
[4,101]. Both toxins were shown to elicit erythematous and 
hemorrhagic skin reactions when injected into rabbit skin in 
nanogram amounts [58,102]. Administration of the toxins to 
experimental animals culminates in recognized symptoms of Ç. 
difficile induced cecitis, suggesting that the toxins alone 
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TABLE 3. SUMMARY OF BIOLOGIC CHARACTERISTICS OF C. 
difficile TOXINS A and B. 
ACTIVITY TESTED TOXIN A TOXIN B 
Cytotoxicity + + + 
Rabbit ileal loop test 
Fluid response (mouse) + 
Lethality (rodents) 




are responsible at least for inducing the symptoms, if not 
the disease process [61]. 
Both toxins A and B are expressed by all toxigenic 
strains of Ç. difficile but are completely absent in non- 
toxigenic strains [62] . Various amounts of toxins are 
produced by different strains but a 1:1 ratio of toxin A to 
toxin B is always maintained. These findings give a strong 
indication that both toxins may be related at either trans¬ 
criptional regulation, or at the translational level. This 
ratio also suggests the existence of synergistic action 
between the toxins in mediating pseudomembranous colitis 
[49,61,99]. Both toxins have since been determined to be 
essential in the pathogenesis of the disease. In 1982, 
Libby et al. [55] showed that administration of toxoids 
containing either toxins A or toxin B did not protect 
animals from clindamycin-associated colitis, except when 
animals were vaccinated simultaneously with both toxoids. 
The mechanisms involved are not clear but it is the 
concensus that toxin A may play a more important role in the 
pathogenesis of Ç. difficile-associated ileocecitis by 
sensitizing the colon for toxin B, possibly through increas¬ 
ing permeability of the mucosa [61]. Evidence in support of 
this conjecture was recently documented by Kim et al. [49] 
by showing that adult female hamsters were protected against 
Ç. difficile-associated ileocecitis upon immunization with 
toxoid A or a mixture containing both toxoids A and B. 
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Neither immunization with broth filtrate from nontoxigenic 
strains nor toxoid B alone conferred protection against the 
disease [49]. 
A mild cytotoxic activity is reportedly associated with 
toxin A. Nonetheless, results of immunologic assays have 
revealed an absence of cross reactivity between both protein 
molecules, as antisera prepared against toxin A only neutra¬ 
lized biological activities associated with toxin A, while 
being ineffective against toxin B [37]. Therefore, the 
cytotoxic activity associated with the enterotoxin is 
endogenous, and cannot be attributed to a contamination from 
toxin B. Finally, it was hypothesized that both proteins 
may share one or more common immunodeterminants since 
selective monoclonal antibodies generated against one toxin, 
showed some cross-reactivity with the other toxin in enzyme 
immunoassays [58,88,117] 
Mechanisms of Toxin Action 
A number of investigators have explored the mechanism 
by which toxin B acts on mammalian cells. Ç. difficile 
toxin B has been shown to exert its effect on cell shape 
through disaggregation of actin in contrast to other 
clostridial toxins, which are phospholipase or hemolytic- 
dependent [28,94]. Using indirect immunoflorescence and 
anti-actin antibodies, Thelestam and Bronnegard [105] demon¬ 
strated that Ç. difficile cytotoxin induced a progressive 
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disruption of actin containing microfilament bundles in 
human lung fibroblasts, and inhibited the synthesis of 
proteins and nucleic acids without damage to other cellular 
organelles. Similar structural alterations have been obser¬ 
ved from EM studies of myofilament bundles of smooth muscle 
cells intoxicated with toxin B [114]. 
The morphological and cytoskeletal effects induced by 
toxin B show a strong similarity to those of cytochalasin B, 
a fungal alkaloid, reported to inhibit cellular movement by 
binding reversibly to the barbed end of actin containing 
filaments [32] . Support for the proposed action of toxin B 
has been demonstrated in investigations designed to study 
the specificity for fibroblast actin and related components 
of cytoskeleton. In a series of studies employing inhibi¬ 
tion assays, Pothoulakis et al. [80] were able to correlate 
an increase in ratio of globular to filamentous actin of 
fibroblast cells to a dose-dependency brought about by Ç. 
difficile cytotoxin. More recently, Ottlinger and Lin [78], 
upon examining the localization of several cytoskeletal 
elements in cell lines treated with toxin B, observed a 
depolymerzation and reorganization of actin stress fibers as 
well as microtubular and intermediated filament network 
prior to morphological changes in the cell. However, the 
extent of depolymerization seen was reported to be rela¬ 
tively small, suggesting that actin reorganization and not 
depolymerization is the dominant cellular response to toxin 
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B. Along with F-actin, localization of vinculin and talin 
(elements involved in maintaining cell shape and motility) 
in intoxicated cells was shown to parallel those seen in 
phorbolester-treated or virally transformed cells [78]. Ç. 
difficile cytotoxin, therefore, may affect one or more 
cellular components that regulate the structure and function 
of the actin cytoskeleton. 
Numerous efforts have been made in an attempt to 
localize and identify toxin receptors on mammalian cells. 
Heat-labile bacterial enterotoxins are known to cause fluid 
accumulation by activating adenylate cyclase and increasing 
the intracellular pool of cAMP after binding to receptors 
[115]. Vesely et al. [110] demonstrated that Ç. difficile 
toxin B elevated the activity of intracellular pool of 
guanylate cyclase while inhibiting the activity of adenylate 
cyclase. This type of response is similar to that observed 
with heat-stable enterotoxins of Yersinia enterocolitica and 
Escherichia coli [63,110]. The stimulation of guanylate 
cyclase was observed by Lyerly and Wilkins [63] to be 
additive in the presence of both toxins, suggesting that 
different receptors are being recognized by the toxins. 
Receptors for toxin A have been identified on rabbit 
erythrocytes membranes and on brush border membranes from 
hamsters. The receptor on rabbit erythrocytes is a glyco¬ 
protein which has been successfully isolated in an inactive 
form, employing the agglutinating tendencies of red cells 
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treated with the toxin. Krivan et al. [51] showed that this 
binding is due to formation of a glycoconjugate between a 
region on the toxin and galactose-a-l-3-galactose-(3-l-4-N- 
acetylglucosamine sequences on the rabbit erythrocyte 
receptors. It is currently speculated that toxin A may 
contain repeating subunits because it agglutinates rabbit 
erythrocytes and can be precipitated with certain monoclonal 
antibodies [117]. 
A receptor for toxin B on mammalian cells remains 
elusive, and is yet to be identified, but preliminary 
results have been reported [33]. Despite the preliminary 
status of toxin B receptor experiments, the present 
speculation is that a lipid domain may be involved in the 
process of binding of toxin B to membranes [63], since 
binding was inhibited when cells were pretreated with 
protease [104], and either sterols or bile acids, but not 
with carbohydrates [19]. 
It is unknown whether the binding of toxin B to mamma¬ 
lian cells is an energy dependent process. Binding of toxin 
B to fibroblast surface was reported by Thelestam and Florin 
[106] to occur at low temperatures (0°C) for at least 20 h, 
an observation which implied that cell binding potential of 
Ç. difficile cytotoxin does not require an active metabolic 
state, hence is energy independent. Nonetheless, cell bind¬ 
ing at ambient temperature was observed to be inhibited in 
the presence of dinitrophenol indicating that binding may be 
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an energy requiring process [63]. Because of the hydro- 
phobicity of toxin B, it is highly conceiveable that binding 
and cytotoxicity occurs via toxin membrane interaction. 
Genetic Studies 
The ability to reliably manipulate genetic elements has 
proven invaluable in delineating the functional and bio¬ 
chemical characteristics of cells and the proteins they 
express. This approach allows more rapid, extensive and 
convenient collection of data than would be possible by 
using conventional methods. For instance, restriction endo¬ 
nuclease patterns of chromosomal and plasmid DNA's have been 
used extensively to gain insight into the epidemiology of 
several bacterial infections [14,50,112]. Attempts to 
establish serotyping, plasmid analysis, protein profiles or 
bacteriophage typing as a means to distinguish between 
different isolates of Ç. difficile have proven technically 
difficult, time consuming, and has a limited ability to 
discriminate between strains [42,76,73,91,97,113,118]. 
Within the past year, however, several investigators have 
documented the success and usefulness of restriction 
endonuclease analysis of chromosomal DNA as a typing method 
for Ch_ difficile [25,52,75,121]. Unique restriction endo¬ 
nuclease patterns obtained in all cases were reported to be 
strain specific and corresponded with known antibiotic 
susceptibility profiles [52,121]. 
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There have been published reports of isolation of self- 
transferable resistant plasmids from anaerobic bacteria 
during the past few years [15,65,90]. In C. difficile, tet¬ 
racycline resistance (Tetr) has been shown to be trans¬ 
ferable between different strains in a fashion that 
precludes simultaneous exchange of other resistant markers 
[91,122]. Low frequency transfer of the chromosomally 
located Tetr determinants was reported to occur only through 
conjugation, but the mechanisms by which the process is 
achieved remains unclear [39,93,122]. These demonstrations 
imply that other antibiotic determinants, and possibly toxin 
determinants, may be conjugally delivered between strains 
which would have a tremendous clinical consequence. 
Research Objective 
The molecular basis for control of expression of Ç. 
difficile enterotoxin and cytotoxin genes implicated as the 
primary factors in antibiotic-associated diarrhea and 
pseudomembranous colitis is yet to be investigated to any 
extent. With the exception of few recent and fundamental 
publications on the molecular biology of Ç. difficile, most 
studies have focused on biochemical, biological, or clinical 
manifestations of the organism. An indepth study of the 
genetic determinants of Ç. difficile at the molecular level 
is essential in order to fully understand its pathogenesis. 
The general aim of the study documented herein was to set a 
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framework for extensive analysis on the regulation of 
expression and structural dimensions of the toxin genes of 
C. difficile. Specifically, this investigation was designed 
to meet the following objectives: 
1. Develop a reliable procedure for the isolation and 
manipulation of C. difficile chromosomal DNA. 
2. Construct a library of Ç. difficile genome in 
bacteriophage Xgtll. 
3. Isolate Ç. difficile toxin A determinants from the 
genomic library construct. 
4. Characterize isolated toxin A determinants. 
5. Isolate Ç. difficile toxin B determinants from the 
genomic library construct. 
6. Characterize isolated toxin B determinants. 
7. Subclone stable toxin A gene fragments in single- 
stranded Ml3 bacteriophage. 
8. Partially sequence toxin A determinants success¬ 
fully subcloned in M13 bacteriophage. 
CHAPTER III 
MATERIALS AND METHODS 
Ç. difficile Toxin Isolation and Antitoxin Production 
The isolation and purification of Ç. difficile toxins A 
and B from toxigenic strain 10463 (supplied by Tracy D. 
Wilkins, Virginia Polytechnic Institute, Blacksburg, 
Virginia) was performed in our laboratory by CL-6B DEAE- 
sepharose column chromatography as described by Sullivan et 
al. [99] with some modifications [74]. Following column 
chromatography, fractions were tested on CHO cells for 
cytotoxic activity. Fractions that contained toxin A and 
several contaminating proteins were pooled, acetic acid 
precipitated at pH 5.5, and loaded on a 1.5 x 15 cm column 
of CL-6B DEAE-sepharose which had been equilibrated with 50 
mM Tris-HCl (pH 7.5). The column was washed with 100 ml of 
the same buffer and eluted with a 200 ml linear 0.05 M to 
0.25 M NaCl gradient in 50 mM Tris-HCl, pH 7.5. Fractions 
containing toxin B were pooled and utilized without further 
manipulations. 
Antiserum against formalin-treated toxins was generated 
in 5 kg New Zealand white rabbits utilizing the procedure of 
Ehrich et al. [30]. Formalin-inactivated toxins were mixed 
with incomplete Freud's adjuvant prior to intramuscular 
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injection of experimental animals. Rabbits were bled weekly 
and antibody titer monitored through dot-blot assay using 
Bio-Rad antibody detection kit. 
Isolation of Ç. difficile Chromosomal DNA 
Isolation of high molecular weight chromosomal DNA from 
Ç. difficile was accomplished by growing strain 10463 to 
stationary phase in one liter of brain heart infusion media 
(Difco) containing 10 mg/ml lysozyme (Sigma Chemical Co., 
St. Louis, Mo.). The pelleted cells (3,000 x g for 10 min) 
were washed in TSE buffer (25 mM Tris, 10% sucrose, 0.1 M 
EDTA pH 8.0), and resuspended in 40 ml of TSE with an 
increased EDTA concentration of 0.25 M. Lysozyme was added 
to a final concentration of 35 mg/ml and incubated at 25°C 
for 1 h. An equal volume of 0.25 M EDTA (pH 8) saturated 
with SDS (Sigma) was added, mixed gently for 5 to 20 seconds 
and extracted immediately with one volume of a 1:1 mixture 
of phenol and isoamyl alcohol-treated chloroform. Four 
additional phenol : chloroform extractions and one chloroform- 
isoamyl alcohol extraction were performed and salt 
concentration of aqueous phase adjusted to 0.3 M with sodium 
acetate (NaOAc). The chromosomal DNA was concentrated with 
two volumes of 95% ethanol for 45 min at -70°C, centrifuged 
in an eppendorf microcentrifuge at 4°C for 15 min, and 
washed in ice cold 70% ethanol. The visible pellet was 
dessicated under a stream of nitrogen, resuspended in 
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sterile deionized water and quantitated on a 0.8% agarose 
gel. Ethidium bromide was used as stain prior to 
visualization of gel with ultraviolet lamp. 
Construction of Ç. difficile Genomic Library 
Generation and méthylation of insert fragments. 
The cloning and propagation of Ç. difficile genomic 
library was accomplished in the Xgtll expression system as 
described by Huynh et al. (46), and Young and Davis 
[124,125] with modifications. C. difficile chromosomal DNA 
(5 |lg) was successively cleaved with 25 U of Taal at 65°C 
over a time period of 10 to 30 min to generate a range of 
fragments approximately 1 to 10 kbp in length, suitable for 
insertion into Xgtll vector DNA. Restricted chromosomal DNA 
was extracted with one volume phenol : chloroform:isoamyl 
alcohol (25:24:1), ethanol precipitated, and washed with 70% 
ethanol. The pellet was dessicated in a vacuum desiccator 
and resuspended in EcoRI methylase buffer (100 mM Tris-HCl, 
pH 8.0, 10 mM EDTA, 80 JIM S-adenosylmethionine, and 400 
|ig/ml nuclease free bovine serum albumin) . EcoRI methylase 
(New England Bio Labs) was added to a final concentration of 
5 U/jll and incubated at 37°C for 1 h. Extent of protection 
was determined by addition of 10 U EcoRI endonuclease per 
microgram DNA, adjusting reaction buffer to 50 mM sodium 
chloride, 25 mM magnesium chloride and incubating at 37°C 
for 30 min. The remaining restriction endonuclease activity 
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was terminated by increasing the temperature to 65°C 
followed by extraction with organic solvents and 
precipitation with ethanol. The pellet was evaporated to 
dryness, resuspended in TE buffer and analyzed on 0.8% 
agarose gel as previously described. 
Ligation of adaptors to genomic DNA restriction fragments. 
Three different size Clal-EcoRI conversion adaptors (20 
[1M) solubilized in 50 (il T4 ligase buffer (50 mM Tris, pH 
7.5, 10 mM MgCl, 10 mM DTT) were added in 10 M excess to 2 
(ig methylated Ç. difficile DNA. The duplex oligonucleotide 
adaptor was a donation from C.K. Stover and E. Oaks, Walter 
Reed Army Research Institute, Washington D.C. Ligation of 
adaptor-insert DNA was accomplished by mixing 10 mM freshly 
prepared ATP (0.5 [II) and 40 U of T4 DNA ligase with the 
adaptor-insert fragments, and incubating between 16°C and 
20°C overnight. Because of the single-stranded nick in the 
adaptor-insert molecule, temperatures were maintained below 
50°C, the melting temperature of the duplex oligonucleotide. 
Ligase activity was inactivated by a single 
phenol : chloroform:isoamyl (25:24:1) extraction and two 
chloroform:isoamyl (24:1) extraction to remove residual 
phenol. The adapted chromosomal restriction fragment DNA 
was then precipitated, resuspended in TE and concatenated 
adapters cleaved with EcoRI at 37°C for 1 h. 
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Removal of excess oligonucleotide adaptors. 
Enzyme activity present in the ligation mixture was 
destroyed by extraction with organic solvents, and the 
volume adjusted to 100 (ll with sterile water. High 
molecular weight DNA was selectively precipitated by 
addition of an equal volume of 13% polyethylene glycol (PEG) 
in 1.5 M sodium chloride (PEG solution). DNA precipitation 
was done on ice for 1 h and pelleted in eppendorf 
microcentrifuge for 10 min at 4°C. The supernatant was 
carefully decanted and DNA precipitate washed with 200 (ll of 
a 1:1 dilution of PEG solution in water. The DNA pellet, 
which was invisible at this point, was resuspended in 50 (ll 
TE, reprecipitated as described, then rinsed twice in 70% 
ethanol to remove excess salt. 
Phosphorylation of adapted chromosomal DNA fragments. 
The 5' ends of the adaptor insert DNA was prepared for 
ligation into A,gtll by phosphorylation with T4 
polynucleotide kinase. Following PEG fractionation of high 
molecular weight DNA, the pellet was dissolved in 50 |ll 
ligation buffer and incubated with 1 U of T4 polynucleotide 
kinase at 37°C for 30 min. Kinase reaction was stopped by 
extracting the aqueous phase with organic solvents. The 
phosphorylated DNA was concentrated with ethanol, washed and 
dessicated, then resuspended in ligation buffer. 
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Ligation of adaptor-modified DNA to fart11 and packaging of 
C. difficile genomic library. 
Ç. difficile oligonucleotide-adapted DNA was ligated to 
the unique EcoRI restriction site of dephosphorylated Xgtll 
vector DNA (Promega Biotech. Madison, WI. ) with T4 DNA 
ligase. A 1:1 molar ratio of vector to insert DNA was 
ligated and packaged using a commercial packaging kit 
(Packagene) purchased from Promega Biotech. The packaging 
reaction was diluted 25-fold in phage buffer (50 mM Tris pH 
7.4, and 10 mM MgSO/j) and screened directly in host E. coli 
Y1090 without amplification. The library was stored with 
one drop of chloroform at 4°C. 
Screening of Ç. difficile Genomic Library for Toxin Positive 
Recombinant Bacteriophages 
Adsorption of antiserum for screening and antibody select. 
Overnight cultures of E. coli BNN97 and Y1090 (Promega 
Biotech, Madison, WI.) were grown separately in 25 ml Luria- 
Bertani (LB) medium (10 g Bacto tryptone, 5 g Bacto yeast 
extract, and 10 g NaCl per liter distilled water, pH 7.5) at 
37°C. The BNN97 culture was transferred to 2 liter LB at 
37°C with maximum aeration until ODggo was approximately 
0.6. Lysis was thereafter induced by quickly transferring 
the culture flask to a 45°C stationary water bath with 
periodic agitation for 20 min, then returning the flask to a 
37°C water bath with constant agitation for additional 3 h. 
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The Y1090 culture was likewise transferred to 4 liters 
of prewarmed (37°C) LB, and growth continued with constant 
agitation until an ODggo of 0.6 to 0.7 was achieved. Both 
strains of bacteria were pelleted separately by spinning at 
8,000 x g for 10 min and resuspended in 50 ml of 10 mM Tris, 
pH 7.4. PMSF (Sigma, St. Louis, Mo.) was added to a final 
concentration of 5 |1M and the suspension was sonicated for 
three-30 sec intervals. To expose the major outer membrane 
proteins, Triton X-100 (Sigma) was added to the sonicated 
Y1090 suspension to a final concentration of 2%, and 
incubated at 37°C for 1 h with mild shaking. Phases of the 
suspension were separated by centrifugation at 3,600 x g, 
and the supernatant was decanted and saved. The pellet was 
washed once with 10 mM Tris, pH 7.5, resuspended in 5 ml of 
antiserum to Ç. difficile toxins, adsorbed at room 
temperature for 1 h, and then centrifuged at 25,000 x g for 
20 min at (4°C). Adsorbed supernate was decanted and stored 
on ice. 
The supernatant retained from spinning of sonicated 
Y1090 cells was recentrifuged at 100,000 x g and resulting 
pellet mixed with both sonicated BNN97 lysogen and adsorbed 
antiserum from the last step. Incubation of mixture at room 
temperature was allowed to proceed for 3 h before additional 
centrifugation at 100,000 x g for 1 h. Supernatant 
containing antibodies to the toxins was decanted and stored 
in 2 ml aliquots at -70°C. 
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Screening of genomic library for toxin positive bacterio¬ 
phages . 
Ç. difficile gene library was screened for toxin 
positive recombinants by a modified method similar to that 
described by Russel et al.[89]. A single colony of 
bacterial host strains Y1090 (hsdM+,hsdR~,lon~) was grown 
overnight in LB containing 0.2% maltose, 10 mM MgSC>4, and 50 
jlg/ml ampicillin. A.gtll bacteriophage DNA library was 
plated out on the overnight E. coli Y1090 to give appro¬ 
ximately 7,000 p.f.u. per 150 mm diameter plate. Calcium 
chloride (10 mM), MgC12 (10 mM) and maltose(0.2%) were added 
to the cell/phage mix and incubated at room temperature for 
15 min to allow for phage adsorption. Cells were plated by 
adding 7.5 ml molten 0.7% LB top agarose warmed to 50°C, 
mixed by multiple tube inversions and plated on dry surface 
of fresh agar plates (LB with 1.5% agar) . Plates were 
incubated at 42°C until the beginning of plaques formation, 
approximately 3 h. Circular nitrocellulose membranes 
(Schleicher and Schuell, Keene, NH.), previously soaked in 
10 mM isopropyl-beta-D-thiogalactopyranoside (IPTG) and air 
dried, were overlaid on the agar surface for 9 to 14 h at 
37°C to adsorb antigenic products during plaque development. 
Position of nitrocellulose membranes relative to agar 
surface were marked before the membranes were carefully 
removed, rinsed briefly in TBST (50 mM Tris-HCl, pH 8.0, 1.5 
M NaCl and 0.5% Tween 20) with contact surface up, and 
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soaked 45 min in blocking solution (20 % fetal calf serum or 
1 % bovine serum albumin in TBST). Adsorbed antisera were 
diluted 200 fold in TBST, before transferring membranes from 
blocking solution. Filters were agitated in diluted 
antiserum on a shaker platform at room temperature for 1 h, 
then removed and washed gently in TBST for 10 min to remove 
unbound antibody. This process involved two washes in TBST, 
5 min each, with gentle agitation. Washed antibody-bound 
filters were thereafter, incubated for an additional 1 h 
period in a 3,000-fold dilution of affinity-purified, 
horseradish peroxidase conjugated goat anti-rabbit 
immunoglobulin (Bio-Rad, Richmond, California). Following 
secondary antibody incubation, the filters were washed again 
as previously described, and rinsed in TBS (50 mM Tris-HCl 
pH 8.0, 1.5 M NaCl) prior to color development. 
Membrane development and picking of positive plaques. 
Horseradish peroxidase color reagent solution (Bio-Rad) 
containing 4-chloro-l-naphthol, prepared according to 
manufacturers suggested protocol, was used in filter 
development. Antigen-antibody complex bound membranes were 
immersed into development solution with mild shaking at room 
temperature until purple dots appeared. Color and 
background development were stopped by washing membranes in 
distilled water for 10 min. Developed membranes were 
thereafter dried on clean filter papers and realigned to 
original positions on assay plates. Positive plaques were 
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picked as agar plugs, using sterile pasteur pipets, and 
suspended in 500 (ll phage buffer. This suspension was kept 
at room temperature for 30 min with a drop of chloroform 
prior to storage at 4°C. 
A homogeneous population of pure positive phages was 
obtained from each plaque through plaque purification. 
Serial dilutions of plaques were performed in phage buffer, 
and 100 |ll of each dilution was plated on host strain Y1090. 
Following 3 h of incubation at 42°C, IPTG impregnated 
nitrocellulose membranes were overlaid on the plates with a 
temperature shift to 37°C overnight. Membranes were 
processed in primary and secondary antibodies, and developed 
as previously described. Isolated positive plaques were 
picked and resuspended in phage buffer with a drop of 
chloroform. 
Restriction Endonuclease Analysis of Recombinant 
Bacteriophages. 
Toxin positive recombinant plaques were plated on Y1090 
as described in plaque enrichment procedure, with the 
following modifications. A 20 mg/ml solution of 5-bromo-4- 
chloro-3-indolyl-beta-D-galactoside (X-gal) in N,N, 
dimethylformamide (Sigma) was added to the top agarose to 
give a final concentration of 0.2% before plating. This 
allowed for colormetric selection of positive plaques from 
revertants. An overnight Y1090 culture was diluted 10-fold 
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in 40 ml LB (ODggo of 0.1 to 0.2.) and one clear plaque 
transferred from each plate and allowed to shake vigorously 
at 42°C until lysis of bacteria was evident. Intact 
bacterial cells were lysed with chloroform and cellular 
debris were removed by spinning at 3, 000 x g for 10 min. 
The supernatant was decanted and diluted with 40 ml of phage 
buffer. DNase I was added to 10 jig/ml, RNase A to 1 ug/ml, 
and the lysate was left at room temperature for 15 min. One 
volume of 20% polyethyleneglycol-6000 (PEG) in 2M NaCl was 
mixed with the lysate and chilled on ice for 30 min to 1 h. 
Precipitated bacteriophages were recovered at 10,000 x g, 
resuspended in 1.2 ml of phage buffer and extracted with an 
equal volume of chloroform. Aqueous phase was adjusted to 
25 mM EDTA and 25 JIM NaCl then extracted with one volume of 
buffered phenol. Two additional chloroform extractions were 
performed and DNA precipitated with two volumes of ethanol 
at -70°C. Pelleted DNA was dissolved in 400 |ll of 0.3 M 
sodium acetate (NaOAc), pH 8.0., recovered and washed once 
more as previously outlined. Finally, the pellet was 
dessicated under vacuum, solubilized in TE and quantitated 
on 0.8% agarose gel. 
Using this DNA preparation, the size of the insert was 
determined by digesting an aliquot (1-3 \lg) with Kpnl and 
Sacl (toxin A recombinants) , or EcoRI (toxin B recombinants) 
and resolving the insert from vector on a 1.0% agarose gel. 
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The gel was stained with ethidium bromide and photographed 
using an ultraviolet lamp. 
Immunologic Identification of Cloned Genes 
Affinity purification of toxin A antibodies. 
Antibodies specific for toxin-positive peptides, 
encoded by recombinant Xqtll phage particles, were affinity- 
purified from toxin A antiserum using the procedure 
described by Lyon et ai. [64] with the following variations. 
Recombinant phage were plated at a density of approximately 
10,000 plaques, just enough to form a confluency on 150 mm 
plate. Nitrocellulose filters were overlaid on the agar 
plates and incubated at 37°C for 16 h to allow for binding 
of antigens. The filters were removed and suspended 
overnight in a 1:50 dilution of E. coli adsorbed toxin A 
antiserum. After washing the nitrocellulose paper twice in 
TBST and once in 10 ml saline, specific antibodies which 
bound to the filters were eluted with 10 ml of glycine 
buffer (0.2 M glycine, and 0.15 M NaCl, pH 2.8) for 10 min. 
Next, the nitrocellulose paper was removed from the highly 
acidic buffer, pH neutralized with 8 mg Tris per ml of 
eluate, and preserved at -70°C [32]. 
Affinity purification of toxin B antibodies. 
Antibodies specific for toxin B or recombinant phages 
were affinity-purified from toxin B polyvalent antiserum, 
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using the antibody select procedure as described previously. 
Purifying antibodies specific for toxin B was initiated by 
running a preparative gel of partially purified toxin B, 
Western blotting to a nitrocellulose filter, and then 
cutting the major cytotoxin band from the filter. Affinity 
purification of antibodies specific for positive clones were 
performed by plaquing each of the recombinants to confluency 
on E. coli Y1090 and overlaying the developing plaques with 
nitrocellulose filters. Antigen - bound filters from the 
Western blot and the recombinant plaques were then incubated 
with a 1:50 dilution of toxin B antiserum. Filters were 
washed twice in TBST and once in physiologic saline. 
Specific antibodies, which bound to the filters, were eluted 
by adding 5 to 10 ml of glycine buffer (0.2 M glycine, 0.15 
M NaCl, pH 2.8) for 30 min and pH neutralized with 8 mg Tris 
per ml. 
Western analysis of toxin A. 
Non denaturing polyacrylamide gel electrophoresis 
(PAGE) of toxin A was performed in a 5% to 15% gradient slab 
gel at pH 8.3 in Tris-glycine buffer at 30 mA [53]. After 
electrophoresis, a single lane was excised from the gel and 
stained with Coomassie brilliant blue R-250. Gel destaining 
solution consisted of a mixture of 35% methanol and 10% 
acetic acid. 
Electrophoretic transfer of proteins from unstained 
section of polyacrylamide gels to nitrocellulose paper 
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(Western blotting) was performed by a combination of methods 
described by Bittner et al. (10] and Towbin et al. [108]. 
Polyacrylamide gels were rinsed in deionized water and 
equilibrated by soaking in blotting buffer (25 mM Tris-Cl 
and 192 mM glycine in 20% methanol, pH 8.3) for 30 min. The 
gels, including one marker lane prestained in Coomassie 
brilliant blue, were carefully placed on buffer saturated 
nitrocellulose membranes in a manner that excluded formation 
of air pockets, and sandwiched between wet Whatman absorbent 
papers. Proteins were transferred by application of 200 mA 
current overnight at 4°C. After electroblotting, membrane 
filters were incubated in recombinant toxin A affinity- 
purified antibodies and processed with Bio-Rad color 
development reagent kit, as described in previous sections. 
Western analysis of Toxin B recombinants expression 
products. 
Toxin B was electrophoresed in a linear gradient of 5%- 
15% non-denaturing polyacrylamide gel at 100 mA for 3 h. 
Production of foreign antigen was accomplished in E. coli 
Y1090 infected with recombinant Xgtll bacteriophage 
particles and induced with IPTG [45,124]. Bacterial debris 
were removed by centrifugation and the supernatants were 
filtered through 0.2 |l amicon filters. The lysates were 
analyzed by fractionation on 7.5% SDS denaturing 
polyacrylamide gels as described by Laemmli [53] . 
Electrophoretic transfer (Western blotting) of either toxin 
39 
B or E. coli cell lysate proteins from polyacrylamide gels, 
to nitrocellulose paper was performed as previously 
described. Filters were probed with toxin B antiserum or 
anti-fi-galactosidase antiserum (Organon Teknica Co., West 
Chester, PA.). Induction of gene expression by IPTG was 
examined by overlaying plaques with two nitrocellulose 
filters soaked either in IPTG or deionized water, and 
adsorbing plaque proteins onto membranes overnight. These 
filters were then developed with antiserum against toxin B. 
Cytotoxicity assay. 
LB cultures of E. coli Y1090 were infected with toxin 
recombinants and induced with IPTG. The cells were 
incubated in a shaker water-bath at 42°C for 2 h and shifted 
to 37°C with maximum aeration until cell lysis was evident. 
Cellular debris were removed by centrifugation at 10,000 x 
g, prior to filtration through a 0.2 |i pore filter. The 
lysates were analyzed for cytotoxicity by overnight incuba¬ 
tion on CHO cells. Antibodies affinity purified, using 
expression products of the recombinants, were also tested 
for their ability to inactivate the toxins. Dilutions of 
the toxins were mixed and incubated at ambient temperature 
for 1 h, then applied on healthy CHO cells. Results were 
recorded after overnight incubation at 37°C. 
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Southern Confirmation of Cloned Toxin A Gene 
Nick translation of toxin A recombinant. 
Nick translation with [a-^^P]dCTP was performed 
according to procedures supplied with Oncor probe labeling 
kit (Oncor, Inc., Gaithersburg, Md.). Enzyme solution 
containing DNA polymerase and DNase I was mixed with cold 
deoxynucleoside triphosphates (30 |IM each of dATP, dGTP, 
dTTP), a labeled deoxynucleoside triphosphate ([a-^P]dCTP), 
and up to 100 ng of toxin A recombinant bacteriophage DNA. 
Nick translation reaction was performed at 15°C for 2 h, 
then terminated by adding EDTA to a final concentration of 
10 mM with subsequent phenol extraction. 
Southern blot and hybridization of labeled probe to C. 
difficile genomic DNA. 
The procedure for hybridization was essentially as 
described by Southern [95] with minor modification as 
provided with the Sure Blot Hybridization kit, (Oncor Inc., 
Gaithersburg, MD.). After a 0.8% agarose gel of Ç. 
difficile chromosomal DNA was subjected to cleavage with 
various restriction enzymes, the DNA fragments were 
depurinated by a 30 min gel immersion in 0.25 N HC1. 
Thereafter, the gel was rinsed in distilled water and 
denatured by incubation in a solution of 0.6 M NaCl in 0.5 N 
NaOH for 45 min. The treated gel was transferred to a flat 
clean surface and a Sure Blot nylon membrane, soaked in 
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dénaturation buffer, was carefully placed on it and covered 
with a filter paper. A stack of paper towels 4 mm thick was 
placed on the filter paper and held in place with a 70 g 
weight. DNA transfer was allowed to proceed for 3 h. The 
DNA-bound nylon membrane was baked in an 80°C oven for 30 
min, then recovered and placed in a heat-sealable polyethy¬ 
lene bag to which 9.0 ml of hybrisol (Oncor hybridization 
solution) was added. Hybrisol contains formamide which 
increases the stringency of DNA-DNA hybridization by 
lowering the melting temperatures of the double-stranded DNA 
molecules [35]. Bubbles were carefully squeezed out of the 
bag prior to heat sealing and prehybridization in a 45°C 
water bath for 1 h. The labelled probe was denatured at 
100°C. An aliquot containing 10^ cpm was mixed with the 
prehybridization reaction and hybridized to chromosomal DNA 
for 16 to 20 h [85]. Following hybridization, the membrane 
was removed and washed three times in 500 ml of 2 x SSC 
solution (17.5 g NaCl, 8.82 g sodium citrate, pH 7.0) 
containing 0.1 % SDS, each wash lasting 15 min. The 
membrane filter was transferred and resealed in a plastic 
bag containing 250 ml wash solution, then placed in a 52°C 
water bath for 1 h. Upon complete hybridization, membranes 
were briefly blotted on filter paper and placed in mylar 
plastic bags. Autoradiography was performed at -70°C for 72 
h in X-ray cassettes with intensifying screens. 
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M13 Bacteriophage Cloning and Partial Sequence Analysis of 
Ç. difficile Toxin A Gene fragment in Xcdl9 
Subcloning of fragment in M13 bacteriophage. 
Recombinant DNA, isolated from clones bearing toxin A 
gene fragment, was double-digested with Kpnl and Sacl 
restriction endonucleases and phenol-cholroform extracted. 
Degree of cleavage was confirmed by electrophoresing an 
aliquot on a 1.0% ethidium bromide stained agarose gel, and 
visualizing with a UV lamp. Replicative forms (RF) of 
single-stranded M13mpl9 and M13mpl8 vectors were double 
digested with Kpnl and Sacl according to suppliers 
instructions, and 5'terminal phosphates removed with 1 U 
calf intestinal alkaline phosphatase (Sigma) at 37°C for 1 
h. The reaction was treated with 1 (ig/ml proteinase K at 
37°C for 30 min to inactivate the enzyme, precipitated, and 
checked on agarose gel electrophoresis as previously 
outlined. A final insert (toxin A gene) to vector ratio of 
5:1 was ligated with 2 U of T4 ligase at 16°C for 4 h 
[24,34] . 
Transformation of competent cells. 
A modified standard high efficiency transformation 
procedure of Hanahan [41] was employed in the transformation 
of E. coli strain JM103 (rk~, mk+) with recombinant molecules 
from the ligation reaction. One colony of JM103, selected 
on minimal medium (M9) plate, was grown in LB until an OD5QQ 
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of 0.3 was achieved. The culture was chilled on ice for 15 
min and pelleted at 1000 x g for 10 min at 4°C. Next, the 
cells were resuspended in l/3rc* growth volume with standard 
TFB (100 mM KC1, 45 mM MnCl^I^O, 10 mM calcium chloride, 3 
mM hexamine cobalt III chloride and 10 mM potassium- 
morpholino ethone sulfonic acid, pH 6.2; Aldrich Chemicals, 
Milwaukee, WI. ) , chilled on ice for 15 min, then centrifuged 
and resuspended in l/50th growth volume with TFB. A 3.5% 
volume of 1 M DTT solubilized in 10 mM KOAc solution, pH 
7.5, and 90% DMSO was added to the cells, followed by a 10 
min incubation on ice. The treatment was repeated and the 
competent cells distributed in 210 |ll aliquots into chilled 
falcon-type polypropylene tubes. Insert-bearing phage DNA 
(100 ng) was carefully mixed with the cells, and incubated 
on ice for 40 min. The cells were heat shocked for 90 sec 
in a 45°C water bath, transferred to an ice bath for 2 min 
and equilibrated to room temperature. To the transformed 
cells, 40 |il IPTG (100 mM) and 40 |ll of a 20% X-gal solution 
in N,N, dimethylformamide was added. Fresh E. coli JM103 
cells (200 |ll) and 3 ml soft agarose (0.7% agarose in LB) 
kept at 48°C, were added to each tube, swirled and overlaid 
immediately unto a prewarmed (37°C) LB plate. The plates 
were incubated overnight at 37°C. 
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Screening of toxin A gene insert and preparation of single- 
stranded DNA for sequencing. 
Cells transformed with recombinant bacteriophages were 
differentiated from non-recombinant bacteriophage trans¬ 
fected cells by virtue of their appearance as colorless 
plaques on assay plates. Recombinant plaques were picked 
with sterile pasteur pipets, resuspended in 500 |ll phage 
buffer and kept at ambient temperature for 30 min. A drop 
of chloroform was added and 20 |ll of phage saturated buffer 
was used to infect 10 ml mid-log JM103 cells grown in LB 
broth. Infected cultures were grown for 10 h at 37°C with 
maximum aeration, then 10 0 |ll of each culture was removed 
and pelleted to screen for presence of insert. Recovered 
cells were resuspended in 200 |ll electrophoresis buffer and 
50 |ll lysis solution (1 % SDS in loading buffer) by vigorous 
agitation for 20 sec. The suspension was incubated at 65°C 
for 30 min, then vortexed for 20 sec, and electrophoresed on 
a 1% agarose gel with appropriate controls. 
Remaining recombinant bacteriophage cultures were 
thereafter transferred to sterile centrifuge tubes and spun 
at 3, 000 x g for 5 min. The supernatant was carefully 
decanted, to avoid breaking up the cell pellet, into another 
sterile tube and recentrifuged as previously. To the cell- 
free supernatant obtained, 800 |il PEG/NaCl solution (20% PEG 
8000 in 2.5 M NaCl) was added, mixed by multiple tube 
inversions and incubated at ambient temperature for 15 min. 
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The tubes were centrifuged at 10, 000 x g for 10 min to 
pellet phage particles. Centrifugation was repeated for 1 
min, and the remaining supernatant removed with drawn-out 
pasteur pipet. A visible bacteriophage pellet observed at 
the bottom of tube was resuspended in 400 |ll phage buffer 
and extracted once with one volume each of buffered phenol, 
and twice with chloroform. Single-stranded bacteriophage 
DNA was precipitated from aqueous phase at -70°C, using one- 
tenth volume 3.0 M NaOAc pH 6.0 and 2.5 volume 95% ethanol. 
DNA pellet was washed in ice-cold 70% ethanol, resuspended 
in 0.5 M NaCl in TE, and purified further on NACS prepac 
resin (BRL Inc., Gaithersburg, MD.), according to 
manufacturers suggested procedures. Following high salt 
elution from resin, the DNA was precipitated as previously 
described and dissolved in TE to 500 ^ig/ml. 
Synthesis and purification of oligonucleotide primers. 
Oligonucleotide primers employed in sequence analysis 
were synthesized on Milligen model 7500 DNA synthesizer 
employing cyanoethyl phosphoramidite chemistry. Following 
synthesis the detritylated oligonucleotides were fully 
deprotected in concentrated ammonium hydroxide (27%) at 55°C 
for 16 h before evaporating to dryness in a rotory 
evaporator. The crude product was resuspended in deionized 
water and quantitated on LKB ultrospec II spectrophotometer 
at 260 nm. Purification of desired full length oligomer 
from failure sequences was achieved by fractionating the 
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crude product on a 32 cm, 10% or 15% polyacrylamide gel at 
1000 V for 2 h. After staining the gel with ethidium 
bromide, the oligomer of interest was excised with a clean 
sterile scalpel, diced into small pieces and placed in an 
eppendorf tube. Sterile deionized water was added to cover 
the gel slices and allowed to sit at ambient temperature 
overnight. Gel particles were thereafter removed and DNA 
containing aqueous solution purified through reverse phase 
chromatography on NACS prepac columns. The ethanol 
precipitated oligonucleotide was resuspended in water until 
a spectrophotometric reading of 0.03 at A-260 was obtained. 
Dideoxv chain termination sequence analysis of toxin A gene 
fragment. 
Determination of toxin A gene fragment sequence was 
done by Sanger dideoxy-chain termination method of DNA 
sequencing, using Sequenase™ polymerase as described by 
Tabor and Richardson [100]. Sequenase sequencing kit was 
obtained from United States Biochemical Corporation 
(Cleveland, OH). All reactions were performed in polypropy¬ 
lene microcentrifuge tubes which were always kept capped to 
minimize evaporation of the small volumes of reactions. To 
1 |lg single-stranded templates, 2 |ll of 5 x sequencing 
buffer, 10 ng of appropriate oligonucleotide primer and 
distilled water were added to a final volume of 10 |il. The 
tubes were capped tightly, warmed to 75°C for 2 min in a 
water-bath, then allowed to cool slowly at room temperature 
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to below 35°C. While the annealing reactions were cooling, 
four sets of tubes for each reaction were marked for 
individual nucleotides and filled with 2.5 (ll of dideoxy 
nucleotide termination mixes. Sequenase™ enzyme and deoxy 
nucleotide labeling solutions were diluted according to 
supplier protocols. To the annealed template-primer, 1 |il 
each of 0.1 M DTT, [a-^^S]dATP (Amersham Corporation, 
Arlington Heights, Illinois) , approximately 10 Ci/(ll, and 2 
[ll diluted labeling mix (dNTP) were added. The 
radioactivity was supplied as triethyammonium salt in 
aqueous solution at 370 MBq/ml (10 mCi/ml) greater than 1000 
Ci/mmol. Finally, 2 (ll sequenase reaction enzyme was 
pipetted into the tubes, mixed thoroughly to start the 
reaction, and transferred to a 20°C water-bath for 5 to 10 
min. Tubes containing dideoxy nucleotide termination mix 
were pre-warmed to 37°C, and 3.5 (ll aliquot of the labeling 
reaction was transferred to each set of tubes with continued 
incubation for an additional 5 min. To read through regions 
of compression, 0.5 (lg single-stranded binding protein 
(Amersham) was included during the labeling reaction and 
dideoxy nucleotide termination was performed at 55°C. A 
pre-mixed stop solution containing deionized formamide was 
added to each reaction to halt chain extension, then stored 
at -20°C until sequencing gels were ready to be loaded. 
48 
Denaturing gel electrophoresis of sequencing reactions. 
Electrophoretic separation of sequencing reactions was 
performed on 8% denaturing polyacrylamide gel (7.6 g acry¬ 
lamide, 0.4 g bis-acrylamide, 42 g urea, 0.035g ammonium 
persulfate, 10 ml of lOx Tris-borate buffer and 50 |ll Temed) 
at 60 W for 3.5 h in Tris-borate buffer. Gels cast on 45 cm 
glass plates treated with 5% dichlorodimethylsilane in 
chloroform was allowed to polymerize for 2 to 4 h and pre¬ 
run for 1.5 h before application of samples. After 
electrophoresis, the gels were soaked briefly (10 min) in a 
mixture of 10% acetic acid and 10% methanol solution to 
remove excessive urea, covered with mylar sheets and dried 
under vacuum at 80°C for 2 h. Autoradiogram was performed 
at room temperature for 36 to 48 h using hyperfilm-betamax 
(Amersham) . The DNA sequence was entered into the 
IBI/Pustell DNA-protein sequence analysis program file and 
analyzed for restriction enzyme sites, translation product, 
amino acid composition and hydropathy profile. 
CHAPTER IV 
RESULTS 
Isolation and Identification of Ç. difficile Toxins and 
Antisera Preparation 
Ç. difficile toxins A and B were isolated from 
toxigenic strain 10463 by a modification of the protocols of 
Sullivan et al (98). Purity of active toxin preparations 
was examined by fractionation on 3%-15% gradient poly¬ 
acrylamide gel and immunoelectrophoresis using antiserum to 
Ç. difficile crude culture supernatant. Toxin A was isola¬ 
ted to homogeneity following isoelectric point precipitation 
as evidenced by presence of a single protein band on 
coomassie blue stained PAGE (Fig. 1), and one zone of preci¬ 
pitation on immunoelectrophoresis. The cytotoxin prepara¬ 
tion on PAGE was observed to consist of one major band in 
association with three poorly visible minor bands (Fig. 1). 
To determine if any band contained toxic activity, 
individual bands were excised from the gel, sliced into 
sections, homogenized, and assayed for cytotoxicity on 
tissue culture cells. Cytotoxic activity was present in the 
predominant band, which was identified to be toxin B. 
Hyperimmune monovalent and polyvalent antisera were 
prepared against formalin inactivated purified enterotoxin 





Gradient PAGE (3%-15%) profile of Ç. 
difficile strain 10463 enterotoxin and cyto- 
toxin preparation stained with Coomassie 
brilliant blue. Toxins were isolated by a 
modification of methods described by Sullivan 
et al. [99]. Arrow indicates band containing 
major cytotoxic activity. 
Purified enterotoxin. 
Partially purified cytotoxin. 
Proteins from crude culture supernatant of 
strain 10463. 
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Zealand white rabbits. Antibody response in the rabbits was 
monitored by immunoblot analysis (Fig. 2) . A strong anti¬ 
body titer was observed for toxin A one week after the 
initial intramuscular injection of inactivated toxin (Fig. 
2, panel A) , whereas, toxin B did not elicit a strong anti¬ 
body response in the rabbit until three weeks following 
initial vaccination (Fig. 2, Panel B). 
Ç. difficile Chromosomal DNA Isolation and Construction of 
X.gtll Recombinant Library 
The difficulties encountered with lysis of Ç. difficile 
cells, extraction, and manipulation of the genomic DNA 
prompted the search for a reliable protocol for DNA 
isolation from the bacteria. A purification procedure was 
developed and described in the materials and methods which 
yields high molecular weight Ç. difficile chromosomal DNA. 
Cell lysis was effected by addition of elevated amounts of 
lysozyme and SDS, and the extraordinary nuclease activity 
associated with the organism inhibited with increased EDTA 
concentration. Although chromosomal DNA isolated with this 
procedure proved resistant to cleavage by a myriad of common 
restriction endonucleases, the DNA was found to be highly 
susceptible to digestion by Taal and Hindlll (Fig. 3). Lack 
of cleavage by common enzymes presented a difficulty in 
finding a suitable cloning vector, since most commercially 




Immunoblot patterns of antibody response to 
toxins in New Zealand white rabbits. Rabbits 
were injected twice each week with formalin 
inactivated toxins in incomplete Freud's 
adjuvant and bled weekly. Production of 
antibody to toxins (0 to 4 weeks) was monito¬ 
red by immuno-blot procedure using 300 ng of 
each toxin, 5 to 25,000-fold dilution of 
antiserum and Bio-Rad blot assay kit. 
Numbers above each panel represent weeks. 
Numbers to the right represent antibody dilu¬ 
tion factors. 
Toxin A antiserum 







Lane 1 : 
Lane 2 : 
Lane 3 : 
Lane 4 : 
Lane 5 : 
Restriction endonuclease (RE) cleavage of Ç. 
difficile, strain 10463 chromosomal DNA. 
Hindi 11 digest of À.DNA and Hael 11 fragments 
of <J)-X174 
Undigested Ç. difficile chromosomal DNA. 
Taql RE cleavage. 
HindiII RE cleavage. 
BamHI RE cleavage. 
EcoRI RE cleavage. Lane 6 : 
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enzyme sites which produce compatible termini to those 
generated by either Tagl or Hindlll. In order to overcome 
this problem, an elaborate strategy which embraced the use 
of conversion adaptors to generate appropriate ends was 
employed. 
A genomic library of Ç. difficile DNA was constructed 
in ^.gtll utilizing, synthetic EcoRI duplex oligonucleotide 
adaptors. Figure 4 depicts a summary of the protocol 
employed to construct Xgtll recombinant expression library 
using these conversion adaptors. Insert DNA fragments of 
approximately 1-10 kbp were generated for the library by a 
partial cleavage of Ç. difficile chromosomal DNA with a 
tetranucleotide recognition enzyme, Tagl. The EcoRI conver¬ 
sion adaptors utilized consist of a 12-base pair palindrome 
core containing an Xmnl cleavage sequence, and terminating 
in 5' Clal restriction endonuclease overhang. Clal genera¬ 
tes an overhang which is complementary to Tagl. Additional 
G+C pairs occupying the 13th or 14th positions were included 
to generate adaptors of three lengths to ensure that 
protein-coding regions were fused in the correct reading 
frames (Fig. 5) . Following ligation of fragments to adap¬ 
tors, concatenates were digested with EcoRI and excess 
adaptors removed by PEG fractionation. Xgtll arms were 
ligated to the adaptor modified insert DNA and packaged to 
generate a library. This library contained approximately 1 
x 107 PFU. Greater than 50% were recombinants as determined 
Fig 4. Schematic diagram for the construction of Ç. 
difficile genomic library in ?igtll using dup¬ 
lex oligonucleotide adaptors. Ç. difficile 
chromosomal DNA restriction fragments genera¬ 
ted with Taal was methylated and ligated to 
the Clal end of unphosphorylated EcoRI 
conversion adaptors. Excess adaptors were 
removed by selective precipitation with PEG. 
The adapted DNA fragments were phosphorylated 
at their 5' EcoRI terminus and ligated to 
EcoRI-cleaved, phosphatase-treated Xgtll vec¬ 
tor. The recombinant ligation mix was packa¬ 
ged and screened with antisera to toxins A 
and B. 
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E. coli V1090 
»*
v 
Fig. 5. Representative sequences of the EcoRI conver¬ 
sion adaptors used for construction of Ç. 
difficile genomic library in Xgt11. The 
adaptor core consist of a 12 base-pair 
palindromic sequence containing an Xmnl site 
(boldface). Two additional adaptors contain¬ 
ing one or two G+C pairs next to the EcoRI 
terminus were also utilized for library 
construction. The three adaptors were 
necessary to ensure that protein-coding 
regions were fused in the correct reading 
frame. The 5,AATT overhang sequence to the 
right of each duplex oligonucleotide adaptor 
represent EcoRI sites whereas the ^' CG 
sequence to the left represent Clal sites. 
[A] GCTTCCCCAAGC-TTAA5’ 
5’CG-CGAAGGGGTTCG 
[B] GCTTCCCCAAGC C-TTAA5’ 
5’CG-CGAAGGGGTTCG G 
[C] GCTTCCCCAAGC CC-TTAA5’ 
5’CG-CGAAGGGGTTCG GG 
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by the appearance of white plaques on plates containing IPTG 
and the chromogenic compound, 5-bromo-4-chloro-3-indolyl-p- 
D-galactoside (X-gal). 
Identification and Characterization of 
Toxin A Determinants 
Approximately 35,000 plaques were screened from C. 
difficile genomic library for toxin A antigen-producing 
recombinants empolying anti-toxin A antiserum propagated in 
rabbit (Fig. 6). Non-specific antibodies, which may interfere 
with the screening process, were absorbed from the antiserum 
using lysates of X,gtll and host E. coli strains. The effi¬ 
ciency of adsorption of the antibodies was verified through 
a Western blot analysis of Ç. difficile and E. coli proteins 
using the absorbed antiserum (Fig. 7). Initial screening of 
the library resulted in detection of twenty-two positive 
plaques (À.Cdl-ÀCd22) encoding toxin A antigens. However, 
only seven isolates retained their inserts after initial 
plaque enrichment. Further passages in the host strain 
resulted in spontaneous loss of inserts in all but one 
(^,cdl9) of the seven remaining recombinant plaques. The 
loss of toxin A DNA inserts from these antigen-producing 
clones was indicated by immunologically testing for the 
presence of toxin A cloned antigens and P-galactosidase 
activity. Bacteriophages, which spontaneously lost their 
inserts (revertants), were distinguished from recombinants by 
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Fig. 6 Pictoral representation of the appearance of 
positive plaques on nitrocellulose membranes. 
Peptides expressed by recombinant plaques 
were bound onto membrane and developed with 
primary antiserum prepared against the 
toxins. Plaques expressing desired polypep¬ 
tides appear as purple concentric circular 
shaped regions on the filter. 
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ANTI-TOXIN A 
ABSORBED WITH E. coli 
E C C A 
Lane 1 : 
Lane 2 : 
Lane 3 : 
Lane 4 : 
Western blot analysis of adsorbed toxin A 
antiserum. Antibody preparations against 
toxin A (and B) were adsorbed with lysates of 
E. coli strains Y1090 and BNN97 to remove 
non-specific antibodies. The effectiveness 
of the procedure was analyzed by developing 
Ç. difficile and E. coli proteins with the 
adsorbed toxin A antisera. 
E. coli Y1090 lysate proteins. 
Ç. difficile toxigenic strain 10463 crude 
culture supernatant. Multiple bands are 
degradation products of the toxin. 
Ç. difficile non-toxigenic strain 4848 crude 
culture supernatant. 
Purified Ç. difficile enterotoxin. 
Fig. 8 Rapid colometric assay for determination of 
insert stability in toxin A antigen producing 
clones isolated from Ç. difficile genomic 
library. Bacteriophages were plated on media 
containing IPTG and X-gal. Revertants pro¬ 
duce active P-galactosidase which degrade X- 
gal to a blue pigment. 
Pannel A: Reverted A,cdl7 showing all negative plaques. 
Pannel B: Xcdl9 showing approximately 2% negative 
plaques. 
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their ability to generate active fi-galactosidase protein, 
and their capacity to produce blue plaques when the host 
strain Y1090 was infected and cultured in the presence of X- 
gal. X,cdl9 was the only recombinant plaque stable enough to 
allow for consistent immunological verification, however, 
this clone reverts from clear to blue plaques at a frequency 
of 2% as shown by analysis, of (3-galactosidase activity 
(Fig. 8) . 
To fully establish that all but one of the positive 
plaques identified from screening of the library sponta¬ 
neously lost their toxin gene inserts, DNA was isolated from 
infected cultures and cleaved with the cloning enzyme, 
EcoRI. A doublet band of approximately 21 kbp was observed 
in all clones including Àcdl9 (data not shown); a profile 
identical to that observed for the non-recombinant Xgtll 
vector. However, following extensive analysis it was evi¬ 
dent that subtle differences existed between the migration 
profile of A.cdl9 doublet and those from the other isolates. 
Since EcoRI digestion did not reveal any details, even in 
kcdl9 which tested positive for presence of insert with X- 
gal, further manipulations were sort to conclusively confirm 
any differences between the clones. The EcoRI cloning site 
in Xgtll is nestled within a 2.08 kb Sacl-Kpnl fragment 
(Fig. 9) . Following a simultaneous cleavage with Kpnl and 
Sacl a 2.08 kb fragment was generated in all isolated 
phages, except Àcdl9 (Fig. 10) . The size of this fragment, 
Fig. 9. Genomic map of Xgtll showing important 
restriction endonuclease sites in kilobase 
pairs. The EcoRI cloning site is nestled 
within a 2.08 kb Konl-Sacl fragment located 
in the modified amino terminus of E. coli 






Lane 1 : 
Lane 2 : 
Lane 3 : 
Lanes 4-9 
Restriction endonuclease profiles of positive 
toxin A recombinant bacteriophages. DNA was 
isolated from phages following multiple 
plaque enrichment, and cleaved with Kpnl and 
Sacl. 
Profile of non-recombinant Xgtll 
bacteriophage. 
Restriction fragments from Hindlll cleavage 
of XDNA and Haell digest of <|)-X174 as molecu¬ 
lar weight references. 
RE profile of Xcdl9 showing a 2.4 kb insert¬ 
bearing fragment. 
: Toxin A recombinants which spontaneously 
lost their inserts. 
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which was also generated from a digest of the non¬ 
recombinant parental vector, confirmed a loss of inserts 
from these initially toxin A positive clones. In the stable 
recombinant X,cdl9, this Sacl-Kpnl fragment increased in size 
from 2.08 kb to approximately 2.40 kb, thereby demonstrating 
the presence of a 0.3 kb insert (Fig. 11, lane 3). The 0.3 
kb Ç. difficile DNA insert in A,cdl9 was further demonstrated 
by hybridizing [a-32P] nick translated Xcdl9 DNA probe to a 
Taal digest of Ç. difficile chromosomal DNA (Fig. 12). The 
labeled probe also hybridized to a 4.5 kb fragment and a 16 
kb fragment in a Pst 1 and Hindi11 restriction endonuclease 
chromosomal digest of Ç. difficile, respectively (Fig. 12). 
Immunological identity of the insert fragment in X,cdl9 
was determined by using Xcdl9 gene product to affinity- 
purify specific antibodies from toxin A antiserum, and using 
these selected antibodies to probe a Western blot of 
purified toxin A (Fig. 13) . Antibodies selected by A.cdl9 
specific gene product was able to develop purified toxin A 
protein immobilized on nitrocellulose membrane (Lane 4) . 
Even though the recombinant Àcdl9 gene product is immuno- 
logically positive for antitoxin A, it does not code for the 
active toxin A protein. E. coli lysates, generated from 
infecting Y1090 with A,cdl9 phage particles induced with 
IPTG, were negative for cytotoxic activity on 3T3 mammalian 
tissue culture cells. 
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Fig. 11. Restriction endonuclease profile of A*cdl9. 
Recombinant DNA was isolated from overnight 
cultures of infected Y1090 and double diges¬ 
ted with Konl and Sacl. 
Lane 1: Profile of non-recombinant Xgtll cleaved with 
Kpnl and Sacl. 
Lane 2: Reference molecular weight from HindiII 
digested À.DNA and Haell fragments of <|>-X174. 
Kpnl-Sacl fragments of Xcdl9. Lane 3 : 
Fig. 12. Southen blot analysis of Ç. difficile 
chromosomal DNA probed with [a-32p]dCTP nick- 
translated Xcdl9 containing 0.3 kb Ç. diffi¬ 
cile toxin A gene fragment. The genomic DNA 
was digested with Tagl, Pstl, and HinduI. 
Labeling and hybridization was performed with 
Oncor kits and radonuclide obtained from 
Amersham Corporation. 
Lane 1: Tagl digest showing hybridization of probe 
with a 0.35 kb fragment. 
Lane 2: Pstl cleavage showing hybridization of X.cdl9 
with 4.5 kb region of the chromosomal DNA 
digest. 
Lane 3: Hindlll cleavage showing hybridization of 
probe with a 16 kb fragment. 
Numbers to the right of the picture repre¬ 




Lane 1 : 
Lane 2 : 
Lane 3 : 
Lane 4 : 
Determination of purity of toxin A and 
confirmation of cloned toxin A determinants. 
Protein was separated by gradient PAGE (3%- 
15%)and Western blot anlysis perfomed as 
described in methods. The primary antibody 
was made against purified toxin A. 
PAGE of purified toxin A. 
Western blot of toxin A developed with a 200- 
fold dilution of toxin A antiserum. 
Western blot of toxin A developed with 
antibodies affinity purified from toxin A 
antiserum using products expressed by non¬ 
recombinant X.gtll palques. 
Western blot of toxin A with antibodies 




Dideoxy Sequence Analysis of Xcdl9 
Based on the knowledge that toxin A gene fragment in 
Xcdl9 was not recoverable from the EcoRI cloning site, a 
Sacl-Kpnl double digest was performed in order to retrieve 
the Ç. difficile insert from the vector for further analy¬ 
tical studies. The excised fragment which contained the 
toxin insert flanked on either side by approximately 1 kb of 
vector (Àgtll) sequence was subcloned in the M13mpl8 and 
M13mpl9 single-stranded vectors. Both vectors differ only 
in orientation of the multiple cloning region. After sub¬ 
cloning, a 1% agarose gel electrophoretic analysis revealed 
that the 7.25 kb M13 vectors increased in size due to 
presence of inserts (Fig. 14). Presence of an intact insert 
was reconfirmed by isolation of the replicative form (RF) of 
the hybrid plasmid followed by subsequent digestion with 
Sacl and Kpnl restriction endonucleases (Fig. 15) . Upon 
confirmation of the insert, single-stranded DNA was isolated 
from both M13 bacteriophages and primed for sequencing with 
a synthetic lacZ 15-mer oligonucleotide. This 15-mer primer 
with the sequence 5'-dG-A-C-T-C-C-T-G-G-A-G-C-C-C-G-3' was 
synthesized on a Milligen 7500 DNA synthesizer by cyanoethyl 
phosporamidite chemistry, which is currently in vogue. The 
full length primer was separated from truncated or failure 
sequences as well as other artifacts of synthesis by frac¬ 
tionation on a 20% denaturing polyacrylamide gel (Fig. 16), 
and purified as described in methods. Evaluation of the 
Fig. 14. Subcloning of toxin A gene fragment in M13 
bacteriophage. DNA was isolated from Xcdl9 
and cleaved successively with Sacl and Konl. 
The fragment containing Ç. difficile insert 
fragment was ligated to M13mpl8 and M13mpl9 
and transformed in JM103. RF DNA was isola¬ 
ted from recombinant plaques and checked on 
agarose gel. 
Lanes 1 and 3: A,cdl9mpl8 and A,cdl9mpl9 bacteriophage 
DNA. Decreased mobility is due to the 2.4 kb 
insert of Xcdl9. 
Lane 2 : Non-recombinant RF of the Ml9 vector. 

Fig. 15. Physical confirmation of toxin A determinant 
in M13 bacteriophage. RF DNA isolated from 
Xcdl9mpl8 and Xcdl9mpl9 were subjected to 
Kpnl-Sacl cleavage. 
Lanes 1,3: X,cdl9mpl8 and Xcdl9mpl9 digested with 
both Konl and Sacl. Insert are represented by 
the 2.4 kb fragments. 
Lanes 2,4: Undigested Xcdl9mpl8 and X,cdl9mpl9. The 
topmost band appearing in both lanes is 
contamination from host chromosomal DNA. The 
middle band is a dimer of the recombinant 
phage DNA. 
Numbers to the left are reference size 
markers. 
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Fig. 16. Purification of synthetic oligonucleotide 
primer. Full length sequences were separated 
from truncated or failure sequences on 20% 
denaturing polyacrylamide gel. The gel was 
stained with ethidium bromide and band (A) 
excised and processed. 




sequence generated with the oligonucleotide lacZ primer 
revealed that it was selectively priming the lacZ region of 
the vector, as opposed to soley priming the region within 
the Kpnl-Sacl insert of Xcdl9. 
In an attempt to hybrid DNA from the recombinant ^,cdl9 
in M13, with a limited amount of Xgtll lacZ sequence 
attached, the M13 hybrid RF subclone which contained the 
Kpnl-Sacl Xcdl9 insert was subjected to double and triple 
digestion using Sacl. Kpnl, and EcoRI (Fig. 17) . Upon 
cleavage with EcoRI and Kpnl two fragments of approximately 
1.02 kb and 1.41 kb were produced (Fig. 17, lane3) . These 
same fragments were present when both enzymes and Sacl were 
used in a triple digestion of the plasmid (lane 1). A dou¬ 
ble digest with Sacl-EcoRI generated a single fragment of 
1.41 kb (lane 2). A 1.41 kb fragment was revealed following 
cleavage of the recombinant with EcoRI, because an EcoRI 
recognition site is in tandem to Sacl recognition sequence 
within the multiple cloning region of M13. The banding 
patterns observed in this experiment revealed that a single 
EcoRI site adjacent to the Sacl site in A,cdl9 was destroyed 
during the initial cloning in A,gtll, thereby preventing 
excision of Ç. difficile insert from ^,cdl9 with EcoRI. 
Figure 18 represents a schematic diagram of restriction 
sites of interest and fragments generated from a Xcdl9 Sacl- 
Kpnl subclone in M13. The 1.4 kb EcoRI-Sacl fragment con¬ 
taining the 0.3 kb Ç. difficile gene was again subcloned in 
Fig 17. 
Lane 1 : 
Lane 2 : 
Lane 3: 
Restriction endonuclease analysis of A,cdl9- 
mpl9. The 2.4 kb fragment from Xcdl9 that 
was subcloned into M13 and maped with key 
restriction enzymes to determine available 
sites. 
^cdl9mpl9 DNA cleaved with Sacl. EcoRI, and 
Kpnl. 
Sacl and EcoRI cleavage. 
EcoRI and Kpnl cleavage. 
A mloecular weight marker for the standard 
HindiII digested XDNA is given on the right. 

Fig. 18. Partial restriction map of Kpnl-Sacl DNA 
fragment from ^.cdl9 subcloned in M13mpl9. 
Thick bar represents toxin A DNA, ( + ) desig¬ 
nates the mutated EcoRI site. Another EcoRI 
















0 ce PH 
w e o e e e 
UJ 0 U 0 a o ^ «m ' P* W-c «te 
PH « ^ « \ (« 
e SL PH Q) PH u 







M13 for sequencing. Due to the presence of the 1.02 kb 
A,gtll lacZ fragment preceding Ç. difficile insert in M13- 
mpl8, the single-stranded recombinant was sequenced with a 
reverse primer whereas, the insert subcloned in M13mpl9 was 
sequenced using Ml3 universal primer. Nucleotide and dedu¬ 
ced amino acid sequences of X,cdl9 are shown in Figure 19. 
The sequence is an open reading frame potentially coding for 
103 amino acids with a calculated molecular weight of 11,076 
daltons. A hydropathic plot of the putative peptide shows a 
large hydrophobic region immediately preceding a predomi¬ 
nantly hydrophylic region (Fig. 20) . Approximately 51% of 
the amino acids specified by A,cdl9 are non-polar, 27% polar, 
11% acidic, and 10% basic (Table 4) . The estimated pi of 
the peptide translated by the nucleotide sequence is 5.9. 
Identification and Characterization of 
Toxin B Determinants 
Polyvalent toxin B antiserum, generated from the 
partially purified toxin B, was used to probe the library 
for toxin B antigen-producing recombinants. Approximately 
60,000 plaques were screened which resulted in the detection 
of 11 toxin positive bacteriophage plaques (XcdBO, XcdBl, 
X,cdB2, XcdB3, X,cdB4, ^.cdB5, XcdB6, XcdBl, X,cdB8, À,cdB9, 
A,cdB10) . Immunological identity of toxin B recombinants 
were confirmed by probing individual clones with antibody 
that was affinity-purified from the major cytotoxin band. 
Fig. 19. Putative nucleotide and amino acid sequence 
of toxin A gene fragment in Xcdl9. The 
numbers above refer to nucleotide positions. 
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Fig. 20. Hydropathy plot of the putative toxin A 
peptide encoded by A.cdl9. The pustel sequence 
analysis program used a window of nine 
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Table 4. Amino acid composition of Xcdl9 toxin gene insert. 
Non-polar: Number Percent 
Ala A 14 13.59E 
Val V 11 10.680 
Leu L 7 6.796 
Ile I 4 3.883 
Pro P 6 5.8E5 
Met M 4 3.883 
Phe F 5 4.854 
Trp W 1 .971 
Polar: Number Percent 
Gly G 5 4.854 
Ser S 6 5.BE5 
Thr T 4 3.883 
Cys C 1 .971 
Tyr Y 2 1.94E 
Asn N 3 2.913 
Gin Q 7 6.796 
Acidic: Number Percent 
Asp D 5 4.854 
Glu E 6 5.BE5 
Basic : Number Percent 
Lys K 2 1.942 
Arg R 6 5.825 
His H 2 1.942 
Unknown: Number Percent 
E 1 .942 
Total AAs = 103 
Calculated Molecular Weight = 11057.980 
Estimated pi = 5.98 
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The process was accomplished by electrophoretically 
separating the major cytotoxic band from minor contaminants 
on a polyacrylamide gel followed by Western blotting onto 
nitrocellulose membrane. The segment of the membrane 
containing the cytotoxic band was excised and used in 
affinity purification of antibodies from the polyvalent 
toxin B antiserum. Peptides expressed by individual plaque 
producing recombinants were bound onto nitrocellulose 
circles and developed with the affinity purified antibodies 
(Fig. 21). 
Size Analysis of Toxin B Cloned Insert DNA 
DNA isolated from toxin B antigen-positive recombinant 
bacteriophage particles were digested with EcoRI for evalua¬ 
tion of cloned insert size on agarose gel electrophoresis. 
Restriction fragments generated revealed the presence of 
three different size DNA inserts ranging from 1.5 kb to 2.5 
kb (Fig. 22) . Three clones contained 1.5 kb inserts, six 
other clones had 1.9 kb inserts, and the remaining two 
positive recombinants contained inserts of 2.5 kb. 
Expression and Characterization of Toxin B 
Recombinant Gene Products 
E. coli Y1090 was infected with toxin B clones and 
resulting cell lysates were evaluated for the nature of 
expressed gene products. Recombinant lysates were 
Fig. 21. Plaque immunoassay for confirmation of toxin 
B determinants. Antigens expressed by recom¬ 
binant plaques in E. coli were adsorbed onto 
miniature nitrocellulose circles (6mm), and 
developed with toxin B affinity purified 
antibodies. 
Circle 1: Non-recombinant Xgtll plaques. 
Circles 2-9: Toxin B positive plaques of recombinants 
X,cdB2, X,cdB4, XcdBl, X,cdB3, ^.cdB5, ?icdB7, 
X,cdB0, and XcdBlO. 
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Fig. 22. Restriction endonuclease profile of toxin B 
gene fragments in Xgtll. DNA was extracted 
from recombinant bacteriophages according to 
standard procedures and cleaved with EcoRI. 
Fragments were separated on a 1% agarose gel. 
Lanes 1, 2, and 8 show the 1.5 kb inserts in XcdB2, 
X.cdB4, and XcdB6 respectively. 
Lanes 3 and 4 show the 2.5 kb inserts in ÀcdBO and 
X,cdB10. 
Lanes 5-7 and 9-11 show the 1.9 kb inserts in XcdB3, 
XcdB5, A.cdB7, ÀcdBl, X,cdB8, and X.cdB9 
respectively. 
Lane 12 contains a combination of Hindlll fragments of 
A.DNA and Haell fragments of <))-X17 4 DNA as 
molecular weight markers. 
00 
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fractionated on SDS polyacrylamide gels, immobilized on 
nitrocellulose membranes by Western blot, and developed with 
either toxin B serum or anti-(3-galactosidase antibody. 
Furthermore, since gene fragments encoding various proteins 
may or may not be expressed as (3-galactosidase fusion 
protein when cloned within the lacZ region of A,gtll exp¬ 
ression vector, plaques from these recombinants were tested 
in the presence or absence of the synthetic lac operon 
inducer IPTG. Recombinants containing either 1.9 kb or 2.5 
kb inserts coded for proteins with Mr of 38,000 which were 
recognized by toxin B antiserum (Fig. 23) . When stained 
with anti-(3-galactosidase antibody, high molecular weight 
fusion peptides (greater than 116,000 daltons) were not 
observed, but a 116, 000 dalton peptide corresponding to (3- 
galactosidase was present in the lysates (Fig. 24) . An 
increase in expression of toxin B antigens were not observed 
for the hybrids containing 1.9 kb or 2.5 kb inserts, in the 
presence of IPTG, confirming that the recombinant products 
of expression were not fused to (3-galactosidase. 
Clones with 1.5 kb DNA inserts generated three distinct 
bands following development with toxin B antiserum, a major 
band with Mr of 56,000, and a minor doublet of approximately 
132,000 and 146,000 daltons, suggesting a possible express¬ 
ion of unstable fused proteins (Fig. 23) . However, when 
analyzed with anti-(3-galactosidase antibody only the 56, 000 
dalton bands were recognized. Neither the high Mr doublets 
Fig. 23. Western blot of Ç. difficile toxin B antigen 
expressed in E. coli Y1090. Recombinant 
infected cell lysates were fractionated on a 
denaturing polyacrylamide gel, immobilized on 
nitrocellulose membranes and probed with 
toxin B antiserum. 
Lane 1: Lysate of Y1090 infected with non-recombinant 
A,gtll phage. The two bands seen in this lane 
which also appears in all other lanes are 
nonspecific cross reacting E. coli proteins. 
Lanes 2-12: Lysates of Y1090 infected with toxin B 
recombinant bacteriophages XcdB2, XcdB4, 
A,cdBl, A.cdB3, X.cdB5, XcdB7, ^cdB8, XcdB19, 
XcdB20, À,cdB0, and À,cdB10 respectively. 
Molecular masses of toxin peptides are shown 
to left of the figure. 
1 23456 789 10 11 12 
146Kd/l32Kd 116 Kd 
97 Kd 
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Fig. 24. Western blot analysis for anti (3-galacto- 
sidase detection of expression products from 
toxin B recombinant bacteriophage. Lysates 
of E. coli Y1090 infected toxin positive 
phages were fractionated on a 3-15% gradient 
polyacrylamide gel, Western blotted onto 
nitrocellulose paper and developed with anti 
P-galactosidase antiserum. 
Lane 1 : Protein profile of the lysate from non¬ 
recombinant X,gtll. 
Lanes 2-7: Profiles of recombinant A,cdB2, XcdB4, 
XcdBl, X,cdB3, X-cdBO, and XcdBlO respectively. 
116 kd 
1 2 3 4 5 6 7 
i — 43 kd 
» • 
•; / .■ . 
— 31 Kd 
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nor the 116,000 dalton P-galactosidase peptides were seen 
(Fig. 24). When these recombinants plaques were analyzed 
for increased expression of toxin B antigens in the presence 
of IPTG, results disclosed that IPTG did not enhance gene 
expression. 
To determine if the recombinant gene products possessed 
biological activity, these peptides were examined for 
possible cytotoxicity, and for their ability to bind to 
neutralizing toxin B antibodies. Inability of the recombi¬ 
nant peptides to induce cell death when tested on CHO cells, 
and failure of antibodies affinity purified from these 
clones to inactivate cytotoxic activity of partially puri¬ 
fied toxin B, indicated that the complete or intact toxin 
protein was not produced by the recombinants. 
CHAPTER V 
DISCUSSION 
Clostridium difficile is a strict anaerobe recognized 
as the major cause of antibiotic-associated colitis. The 
bacterium produces two toxins, toxin A and toxin B whose 
biochemical, and biological characteristics have been 
studied in great details [12,48,56,70,71,72,109]. Toxin A, 
also known as enterotoxin, elicits a fluid response in the 
intestinal tract causing extensive damage to the gut mucosa. 
Toxin B, frequently referred to as Ç. difficile cytotoxin 
initiates the characteristic cell rounding associated with 
cell death by affecting subsidiary proteins involved in 
cytoskeletal maintenance [78]. Both toxins reported to act 
synergistically, are thought to be involved in the patho¬ 
genicity of PMC based on findings that immunity is achieved 
when experimental animals are vaccinated against both toxins 
[49,120], Despite extensive studies on these toxins, major 
controversies concerning their characteristics and disease- 
causing process still plague investigators. To fully eluci¬ 
date the structures of the toxins and to understand how 
their expression are regulated during and after antibiotic 
therapy will require extensive information at the molecular 
level. However, current literature reveals that very few 
laboratories are actively focusing on analysis of C. 
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difficile toxins and their involvement in antibiotic- 
associated colitis at the molecular level. The data descri¬ 
bed in this investigation, represent a framework to ascer¬ 
tain with precision, the structure of toxins A and B as well 
as mechanisms which regulate Ç. difficile gene expression. 
A prerequisite for cloning of specific genes relies 
immensely on the successful isolation of high molecular 
weight chromosomal DNA sufficiently pure for restriction 
endonuclease digestion. Initial technical problems associa¬ 
ted with lysis of Ç. difficile strain 10463, and the 
enormous nuclease activity associated with this bacterium 
prevented use of standard procedures for isolation of high 
molecular weight chromosomal DNA. An isolation procedure 
which yields high molecular weight Ç. difficile chromosomal 
DNA was developed and described in methods and materials. 
Resistance to lysis by standard protocols has been 
documented in other clostridial species. In an effort to 
develop a lysis procedure that approaches existing standard 
protocols, Allcock et al. [2] preconditioned Ç. 
acetobutvlicum by growing cells in medium supplemented with 
0.4% glycine which lead to increased rate of protoplasts 
formation. Delvin et al. [25] in 1987 reported a modified 
procedure in which a four-fold increase in glycine content 
of anaerobic BHI broth enabled complete lysis of Ç. 
difficile. 
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Chromosomal DNA isolated from Ç. difficile strain 10463 
did not digest well upon exposure to a spectrum of common 
restriction enzymes, but did digest in the presence of Tagl, 
a high temperature-functioning enzyme extracted from 
ThermoceIlium aauaticum. These complications associated 
with restriction endonuclease digestion of Ç. difficile 
chromosomal DNA have been verified in several other labora¬ 
tory and seemed to be unique with DNA isolated from this 
bacterium. In a recently published study by Peerbooms et 
al. [79], Ç. difficile DNA was reported to generate discrete 
patterns only when digested with Hindlll. Also, in the pro¬ 
cess of exploring the usefulness of DNA restriction enzyme 
profile as a tool in Ç. difficile surveillance, Kujiper et 
al. [52] reported that of nine restriction endonucleases 
tested only Hindlll produced explicit restriction fragment 
patterns which remained constant throughout their study; 
Wren and Tabaqchali [121] have since corroborated this 
report. Furthermore, after successfully cloning Ç. 
difficile Hindlll DNA fragments in E. coli, Dailey and 
Schloemer [23] alluded to problems with Ç. difficile DNA 
digestion in stating that additional subcloning of isolated 
fragments was prevented by scarcity of restriction 
endonuclease sites. It is therefore, plausible to conclude 
that severe constraints associated with manipulation of Ç. 
difficile chromosomal DNA, are responsible for limited 
studies on the organism at the molecular level. 
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The use of Xgtll as a cloning vector requires that 
foreign genes be inserted into a unique EcoRI site located 
within lacZ, approximately 52 bp upstream from the 
termination sequence. Successful cloning and expression of 
Ç. difficile genomic library in X,gtll system as described by 
Young and Davis [124,125] were facilitated by the use of 
conversion adaptors [98] . This approach was adopted as an 
alternate resort following numerous failures from earlier 
attempts to construct the library in other E. coli vector 
systems. 
Since Xgtll was designed to accommodate DNA fragments 
no greater than 7 kb, it was obvious that multiple screening 
of the library may be required to identify bacteriophages 
containing overlapping segments of full length toxin A gene 
estimated to be about 14 kb in size. However, the toxin A 
gene fragments identified in the initial library screening 
proved unstable after limited passages in the bacterial host 
strain. All but one (approximately 300 bp) of the immunolo- 
gically identified positive recombinants spontaneously lost 
their inserts. In contrast bacteriophages harboring toxin B 
gene fragment inserts remained stable even after multiple 
passages in E. coli host. 
DNA sequences as determined for numerous gram positive 
bacteria, including clostridial species, are rich in A+T 
nucleotide pair. On the other hand DNA sequences of E. coli 
and most gram negative bacteria reveal approximately equal 
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ratios of A+T and G+C nucleotides. The sequence of a 4.7 kb 
toxin A gene fragment reported by Dove et al. [27] indicated 
to a great extent that a major portion of the gene encoding 
Ç. difficile toxin A consists of repeat segments and 
stretchs endowed with A+T nucleotides. It is envisioned 
therefore, that inability of Ç. difficile toxin A gene frag¬ 
ment to be maintained in A,gtll when perpetuated in E. coli 
may be due to the unusually high content of A+T nucleotides, 
which made it less compatible with the host system. 
The toxin A 300 bp gene fragment which was consistently 
verified to be present even after multiple passages in the 
same host may be associated with a modification of the Sacl 
proximal EcoRI cloning juncture thus, masking the presence 
of the fragment. It is also possible that this 300 bp 
sequence was retained because it does not possess 
overwhelming A+T stretch characteristic of various regions 
of the toxin gene. In essence the A+T/G+C ratio of this 
fragment approaches that described for E. coli thereby 
guaranteeing its maintenance within the bacterium. Accord¬ 
ingly, the stable maintenance of toxin B recombinants 
following multiple passages in the host bacterium may also 
be attributed to a balance in nuecleotidyl ratios to that 
which can be tolerated in E. coli, consequently permitting 
its perpetuation within the organism. 
Toxin A is a very large protein with a reported average 
molecular mass of 550,000 daltons. The molecular weight 
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estimations on two-dimensional and denaturing electrophore¬ 
tic gel systems range from 200,000 to 300,000 [4,60,82]. 
Cloning of a 14.3 kb DNA fragment from Ç. difficile in 
À.EMBL3 vector, and expression of a 235, 000 dalton protein 
which exhibited a cytotoxic effect on tissue culture cells 
coupled with rabbit erythrocytes agglutination was reported 
in a recent article [119]. Also, the entire region of a 4.7 
kb toxin A gene sequence reported by Dove et al. [27] 
consisted of an open reading frame with no regulatory 
sequence. This region was later confirmed as the carbohy¬ 
drate-binding portion of toxin A because of its capacity to 
express protein products that agglutinate erythrocytes [81]. 
These observations are significant because they partially 
confirm that the gene for toxin A is large and may make-up 
most of the 16 kb Hindi 11 fragment identified when the 
cloned 0.3 kb fragment was hybridized to a chromosomal 
digest of Ç. difficile (Fig. 12). Since this fragment also 
hybridized to a 4.3 kb fragment generated by Pst1 digestion 
(Fig. 12), it seems to be part of the segment later reported 
by Price et al. [81]. 
An integral part of a successful cloning experiment 
does not rely only on demonstration of presence of a foreign 
gene associated with a cloning vector, but also on confirm¬ 
ing the genes identity. Xgtll was designed for use as a 
cloning system to accomplish this task with minimum effort 
through expression of genes introduced within the modified 
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amino terminus of the E. coli lacZ gene fragment (a-donor). 
This vector utilizes a design which takes advantage of a 
phenomenon known as intracistronic complementation, a 
process whereby a functional protein is produced by aggrega¬ 
tion of two gene products with mutation in the same 
polypeptide chain. When in a host devoid of alpha region of 
P-galactosidase (a-acceptor) the peptide encoded by A,gtll 
interacts with the protein product of the cell to produce an 
aggregate that possesses p-galactosidase activity [69]. Any 
modification of the sequence, for instance, by insertion of 
a foreign gene fragment within this region results in the 
production of an inactive p-galactosidase protein. Gene 
fragments coding for various proteins, however, may or may 
not be expressed as peptides fused to p-galactosidase when 
cloned in A,gtll expression vector. Analysis of peptides 
expressed by toxin B recombinant bacteriophages revealed 
that fusion proteins may not have been assembled by 
recombinants bacteriophages containing the 1.9 kb and 2.5 kb 
inserts; a suggestion supported by low molecular masses of 
the antigenic products expressed by these recombinants, as 
well as presence of a 116,000 dalton P-galactosidase protein 
in lysates of E. coli. Upon further analysis it was confir¬ 
med that open reading frames of these recombinants were not 
fused directly to the p-galactosidase gene since the 
synthetic lactose operon inducer, IPTG, was unable to 
amplify the gene product. Expression of these gene inserts 
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as peptides not coupled to (i-galactosidase invokes the 
speculation that they may have been transcribed from their 
own promoters. This suggestion is consistent with the 
recent report of Dailey and Schloemer [23] identifying a Ç. 
difficile promoter which is functional in E. coli. The 
puzzle as to what sequences influenced regulation and 
expression of each set of recombinants may be solved by 
analyzing the complete nucleotide sequence of the genes. 
Doublet bands of approximately 132,000 and 145,000 Mr 
were observed on Western blots developed with antiserum 
against toxin B for XcdB2, XcdB 4, and ^.cdB6. Since these 
clones contain 1.5 kb DNA inserts which cannot code for 
peptides significantly larger than 60,000 daltons, it is 
likely that these bands represent highly unstable fusion 
proteins or aggregates of the 56,000 daltons peptide. The 
hypothesis that these high molecular weight proteins are 
unstable fusion products can be proposed because a 116,000 
dalton p-galactosidase band was not apparent in Western 
blots of these recombinants; and also because the 56, 000 
dalton peptides react to anti (3-galactosidase antibody, 
suggesting that these fragments contain part of the fi- 
galactosidase peptide fused to the toxin. However, if the 
high molecular weight bands (132,000 and 145,000 Mr) 
represent fusion proteins, then, there is no clear explana¬ 
tion why these bands were recognized by toxin B antiserum 
but not (3-galactosidase antiserum. Similar immuno-blot 
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patterns were reported by Barlow et at. [8] in which outer 
membrane proteins of Neisseria meningitidis were fused to (3- 
galactosidase in Xgtll. A Western blot developed with anti¬ 
bodies against outer membrane proteins demonstrated the 
presence of an intensely stained 156,000 dalton fusion 
protein, but when blots were developed with anti-(3-galacto- 
sidase monoclonal antibody the degradation products of the 
fusion protein predominated. 
There are inherent problems with the fusion protein 
hypothesis for X,cdB2, A,cdB4, and X,cdB6, in that production 
of toxin B gene products does not appear to be inducible 
with IPTG. This would suggest that these proteins are not 
under the control of the (3-galactosidase promoter and these 
proteins should not exist as fusion products. The lack of 
induction requires an alternative hypothesis that the high 
molecular weight doublets are aggregates of the 56,000 
dalton peptide. This may be the case since toxin B has been 
documented to aggregate in solution in response to its 
hydrophobic nature. 
The sequence of toxin A gene fragment shows a protein 
coding region specifying 101 amino acids. The region is 
speculated to encompass epitopes that may elicit strong 
antigenic response in mammalian systems. This conjecture is 
based on the intense reactions of expressed peptide with 
toxin A antiserum and strong hydrophilic regions observed on 
the hydropathy plot. In addition, it is probable that the 
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hydrophobie peaks identified on the same plot may be part of 
the carbohydrate-binding portion reported by Price et al. 
[81]. Furthermore, with a computed pi of 5.92, the poly¬ 
peptide translated from the cloned fragment approaches the 
experimentally established pi value for the complete toxin. 
Data obtained from this study are vital in subsequent 
phases of research in our laboratory. At the moment, radio- 
labeled probe generated from segments of the sequenced toxin 
A gene fragment is being used to screen recombinant Ç. 
difficile genomic library constructed in À2001, in an effort 
to isolate the entire toxin gene intact. 
CHAPTER VI 
SUMMARY AND CONCLUSION 
Ç. difficile is a toxin producing anaerobic bacterium 
implicated as the étiologie agent of a severe form of 
antibiotic-associated diarrhea and colitis named pseudo¬ 
membranous colitis [5, 16,29, 68]. PMC is a disease of the 
lower gastrointestinal tract, associated with colonization 
of the intestine by Ç. difficile following ecological 
disturbance of the intestinal flora after antibiotic therapy 
[13]. The disease is proctosigmoidoscopically diagnosed by 
the presence of exudative plaques on the bowel mucosa. 
Toxigenic Ç. difficile strains produce at least two 
toxins, an enterotoxin commonly known as toxin A which also 
exhibits a weak cytotoxic activity and a potent cytotoxin or 
toxin B devoid of any enterotoxic activity [114] . Both 
toxins possess distinct biochemical and biological proper¬ 
ties and are essential in the pathogenesis of PMC 
[55,58,91,101]. 
Many conflicting reports exist in the literature 
concerning the structural and functional characteristics of 
both toxins. Recently, investigators have been turning to 
genetic analysis in order to consolidate contradictory 
reports issued regarding the physical characteristics of the 
toxins, and to determine the association between C. 
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difficile and PMC. In this study, the toxin genes were 
cloned with the aim of creating a framework for a broader 
project designed to elucidate their physicochemical method 
of action at the molecular level. Experiments conducted 
herein and results obtained are summarized as follows: 
1. Toxin A gene fragments were cloned and expressed in the 
^.gtll expression system. All isolated recombinants 
with the exception of Xcdl9 spontaneously lost their 
inserts. 
2. Affinity purified recombinant product expressed by 
Xcdl9 was specific and highly antigenic for antibodies 
generated against purified Ç. difficile enterotoxin. 
3. Southern blot hybridization analysis of Xcdl9 revealed 
that the insert fragment was a Taal digest of Ç. 
difficile chromosomal DNA, approximately 0.3 kb in 
size. 
4. Toxin A is a very large protein and the size of the 
gene specifying this protein is estimated to be at 
least 14 kb. It is therefore speculated that the 
entire gene sequence may be contained within the 16 kb 
HindiII fragment identified in the hybridization 
studies. 
5. Restriction endonuclease cleavage analysis disclosed 
that the EcoRI cloning site in close proximity to Sacl 
RE site within the lacZ region in Àcdl9 was mutated. 
It is not apparent whether retention of the fragment in 
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Xcdl9 was due to this phenomenon or a function of the 
nucleotidyl composition. 
6. It was speculated from dideoxy sequence analysis that 
recombinant Xcdl9 contained an ORF from toxin A gene 
which encodes a peptide composed of a stretch of 
hydrophobic amino acids in tandem with a hydrophilic 
region. 
7. The putative peptide specified by the fragment has a pi 
similar to experimental values determined for toxin A. 
8. Toxin B gene fragments were successfully cloned and 
isolated in Xgt11. Unlike toxin A recombinants, 
restriction endonuclease cleavage showed that gene 
fragments encoding toxin B were stable in A.gtll. 
9. Inserts identified ranged from 1.5 kb to 2.5 kb in size 
and specified peptides which reacted with antibody 
raised and affinity purified against the Ç. difficile 
cytotoxin. 
10. Expression of toxin B recombinants were independent of 
the presence of the inducing agent, IPTG, suggesting 
the possibility that expression may be initiated from a 
Ç. difficile promoter. 
The successful cloning and partial characterization of 
C. difficile toxins A and B gene segments have been reported 
in this dissertation. Data obtained here will be used to 
further analyze the role of Ç. difficile in the etiology of 
antibiotic-associated PMC. One such immediate application 
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would be to use this information to isolate and fully 
characterize the entire gene and amino acid sequences for 
both toxins. The long term objective of our laboratory is 
to apply the data contained herein towards defining the 
regions which encode epitopes responsible for pathology and 
the immune response of this syndrome, as well as increase 
the knowledge needed to develop a reliable prophylaxis and 
therapy for antibiotic-associated PMC. 
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